Low fat, low lactose diet used as prophylactic treatment of acute intestinal reactions during pelvic radiotherapy. A prospective randomised study by Bye, Asta
Low fat, low lactose diet
used as prophylactic treatment of
acute intestinal reactions
during pelvic radiotherapy
A prospective randomised study
by
Asta Bye
   Norwegian Cancer Society
The Norwegian Radium Hospital,
The Norwegian University of Science and Technology,
Akershus University College, 2002
URN:NBN:no-2118
URN:NBN:no-2118
2Abstract
Purpose. The main aim of the present study was to evaluate the effect of a
low fat, low lactose diet on acute and late gastrointestinal side effects of
pelvic radiotherapy. We also wanted to evaluate if such a treatment would
influence the patients health related quality of life (HRQOL) in any way.
Background. Cancer therapies and their side effects may cause nutritional
problems and malnutrition. Pelvic radiotherapy, a common treatment
modality for patients with carcinoma of the endometrium or cervix,  is
associated with both acute and late side effects that may affect nutritional
status. Acute injury may lead to impaired absorption of nutrients and fluid.
The patients experience diarrhoea, weight loss, nausea and vomiting.  Bile
salt malabsorption may be a factor in the pathogenesis of the diarrhoea. In
cases of bile salt malabsorption a low fat diet will cause decreased bile salt
excretion and thereby relief of symptoms. This assumption was evaluated
in a small, non-randomised study in 1985. The results indicated that a low
fat diet may reduce the frequency of diarrhoea and use of anti-diarrhoeal
agents during radiotherapy. These findings were regarded as promising and
since nutrition management guidelines for radiation enteritis were lacking
in the literature, a clinical trial was planned.
Methods. The study was designed as an open randomised clinical trial and
conducted at the Norwegian Radium Hospital (NRH). The intervention diet
(low fat, low lactose) was to be followed during and six weeks after
radiotherapy. Measurements were performed at basement, the 3rd and last
week of radiotherapy, six week after and then every 8th week. The entire
period was one year. In November 1993 the surviving patients were
approached again and asked to complete a questionnaire package similar to
the one completed during the clinical trial. The study population was
recruited from the department of gynaecology at NRH. The main selection
criteria were pelvic radiotherapy (dose above 40 Gy) age = 75 years and a
WHO functional status = 2. Patients were consecutive included from May
1988 through May 1990 and 143 women were included. Seventy-one were
assigned to the intervention diet and 72 to the control group. In November
1993, 94 women were alive without any known relapse and 79 (84%)
accepted participation. The women registered use of Loperamid and the
daily number and consistency of bowel movements. The data on bowel
movements was categorised and used to evaluate if diarrhoea was present
or not. Nutritional status was evaluated by the means of weight
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3development, arm muscle circumference (AMC), serum transferring (STF)
and serum albumin (s-Alb). Dietary intake was assessed by 48-hour recall
prior to radiotherapy, 4-days unweighed dietary record during radiotherapy
and 7-days weighed dietary records during follow-up. 24-hour urinary
nitrogen was used to validate the food records. HRQOL was defined as the
patients' self-reported subjective physical and psychosocial situation as a
consequence of disease and treatment. It was measured with the EORTC
Core Quality of Life Questionnaire 36-item version (EORTC QLQ-C36).
Results.  During the last week of radiotherapy 14 patients (23%) in the
intervention group and 32 (48%) in the control group reported diarrhoea
(p< 0.01).  The intervention group also used less anti-diarrhoea medication
than the control group, 0.6 tablets per day versus 1.1 (p<0.01). Six weeks
after end of radiotherapy, no group differences were found with regard to
bowel movements or medication. The intervention group had a lower
energy intake than the control group during radiotherapy, 5.7 MJ versus 6.5
MJ (p<0.05). The mean daily fat intake was respectively 34.3 g and 60.1 g
(p<0.001). The intervention group received a significant lower part of the
energy from milk products, meats, fats and sugar than the control group,
and consumed more energy from vegetables and fruits, cereals and fish.
Weight loss was more pronounced in the intervention group (mean
reduction of 2.6 kg versus 1.7 kg) than in the control group (ns) during
treatment. Mean values of AMC, s-Alb and STF were within the reference
range in both groups during the entire observation period. During the last
week of radiotherapy six patients (9%) in the intervention group and 4
(6%) in the control group were mildly depleted (ns). At 12 weeks and after
one year none of the patients could be categorised as malnourished. No
major differences in HRQOL were found between the two groups during
radiotherapy and one-year follow up. Within the control group an
association between diarrhoea and deteriorated role functioning, physical
functioning and fatigue was found during the last week of radiotherapy that
was not found in the intervention group. Regarding late effects of
radiotherapy (3-4 years after radiotherapy) both groups had more diarrhoea
than in the general population, 23.8 versus 9.5 (p<0.01).  There was
however a tendency to more pronounced diarrhoea in the control group
(29.6 (SD=27.3)) than in the intervention group (19.4 (SD=25.4)) though
not statistical significant. Substantial diarrhoea was associated deteriorated
SF and fatigue.
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4Conclusions. The intervention group had less diarrhoea and used less
Loperamide during radiotherapy than the control group. This finding did
not affect nutritional status since no differences in nutritional status were
found between the two groups. Both groups had a reduced energy intake
and weight loss during radiotherapy. In the control group diarrhoea
increased fatigue and had negative effects on physical functioning and role
functioning. The intervention did not lead to differences in late radiation
injury and chronic diarrhoea 3-4 years after treatment but diarrhoea was
most prominent in the control group. Diarrhoea as a late effect increased
fatigue and had a negative influence on social well being.
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 1. Background, aims and research questions
1.1 Introduction
Diet and cancer have a wide interest in the public. How large this interest is
may be reflected in the vast number Internet pages concerning this topic.
When the two words, diet and cancer, are used to search the Internet more
than one million matches may be found.  A lot of this information does not
distinguish between diets to prevent cancer and diets during cancer and
treatment. Such a distinction is however important to make since these diets
may be completely different and have different goals.
It is claimed that about one third of all cancers are related to the diet
(Higginson 1993). Several dietary factors may be of importance as risk
factors as well as protective agents (World Cancer Research Fund 1997).
The causal relations, however, are still unclear and no final conclusions
have been made. The evidence that exist indicates that diets high in
vegetables and fruits are protective (World Cancer Research Fund 1997).
Dietary risk factors are excessive alcohol, fat and energy intake. The
recommendations made for prevention of cancer are generally consistent
with the recommendations given to prevent cardiovascular disease.
While excessive energy intake might be a risk factor in development of
cancer, low energy intake and inability to maintain nutritional status are
common problems for patients with cancer. The disease process, its
treatment and/or psychological reactions can lead to severe protein-calorie
malnutrition which is a major cause of morbidity and mortality in cancer
patients (Donaldson and Lenon 1979, Ottery 1995). Protein-calorie
malnutrition develops when the intake of macronutrients is inadequate to
meet metabolic requirements (Blackburn 1977). The results are progressive
wasting, weakness, compromised immune function, potential therapy
intolerance, and ultimately death. The prognostic impact of weight loss and
malnutrition has been documented since the 1930s in benign disease and
later in malignant disease (Blackburn 1977, Ottery 1995).  It has been
estimated that up to 20% of patients with cancer may die of the effects of
malnutrition and starvation (Donaldson and Lenon 1979, Ottery 1995).
Despite all these observation, it is not documented that any diet therapy
improve survival or enhances possible success of cancer therapy.
URN:NBN:no-2118
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Nutritional problems in cancer patients
Anorexia, cachexia, hypermetabolic state and negative nitrogen balance
which is seen in cancer patients are all effects of the disease process
(Williams 1995B).  Anorexia, defined as loss of appetite or desire to eat, is
the most common symptom among patients with cancer (Bruera and
MacDonald 1988, Ottery 1995). Anorexia is present in 15%-25% of all
cancer patients at the time of diagnosis and is almost universal among
patients with widely metastatic disease (Bozzetti, Agradi and Ravera 1989,
Langstein and Norton 1991).  Normally a lowered energy intake will lead
to a change in body size and composition that eventually results in
decreased energy requirement (Shetty 1999). Cancer patients may,
however, have increased metabolic rate despite low energy intake (Heber
and Tchekmedyian 1999). This may bring the individuals into a wasting
syndrome with symptoms such as weakness, loss of body weight, fat, and
muscle volume, defined as cachexia (Donaldson and Lenon 1979, Williams
1995B).  Anorexia and cachexia may occur together, but cachexia may also
occur in individuals who eat enough to meet energy needs. The exact
mechanisms causing cancer cachexia and anorexia are unknown. Both
anorexia and cachexia may lead to negative nitrogen balance since the
protein intake is decreased and the need is normal or even increased.
Another reason for negative nitrogen balance may be altered protein
matabolism (Tayek 1999). This may be caused by increased uptake of
amino acids by the tumor cells compared with that of normal cells,
decreased protein synthesis, increased protein degradation, and protein loss
through fistulas or by gastrointestinal losses.
Cancer therapies and their side effects can also greatly contribute to
nutritional problems and malnutrition.  Surgery may lead to a wide variety
of problems depending on the affected organ (Williams 1995B). Head and
neck surgery may cause difficulty in chewing and swallowing, gastric
surgery may cause early satiety and dumping syndrome. Pancreatic surgery
may induce protein and fat malabsorption. Chemotherapy may lead to side
effects like anorexia, nausea, vomiting, diarrhoea, constipation,
stomatitis/mucositis, taste alterations, and infectious complications
(Donaldson and Lenon 1979, Ottery 1995). The frequency and severity of
these side effects depend upon the type of drugs, the dose, and whether the
chemotherapy is part of a combined modality program.  Radiation therapy
is associated with both acute and late effects that may affect nutritional
status depending on the site of irradiation (Donaldson and Lenon 1979).
Irradiation of the head and neck area can be associated with anorexia, taste
URN:NBN:no-2118
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alterations or aversions, dry mouth, mucositis, dysphagia, dental caries, and
abscess formation.  Thoracic irradiation may be associated with
esophagitis, dysphagia, esophageal reflux, and nausea and vomiting.
Diarrhoea, nausea and vomiting, enteritis, proctitis, or fistula formations
are possible side effects caused by abdominal or pelvic irradiation.
Pelvic radiotherapy and intestinal reactions
Supportive nutritional care can be offered to relieve some of the negative
effects of cancer and its treatment on nutritional status. The type of
nutritional support will depend on nutritional problems and their causes.
The diet that might be offered must meet the requirements of the particular
condition and be based on modification of the nutritional components of a
normal diet (Williams 1995A).
During the late seventies Andersson, Boseaus and Nyström (1978) showed
that bile salt malabsorption possibly was an important factor in the
pathogenesis of diarrhoea after pelvic radiotherapy. Based on these findings
they evaluated the effect of a low fat diet in a group of patients with
diarrhoea after irradiation (Bosaeus, Andersson and Nyström1979). They
concluded that a low fat diet can be an appropriate therapy since decreased
bile salt excretion and relief of symptoms was seen. They also pointed out
that the diet might be appropriate during radiotherapy. This assumption was
evaluated in a small, non-randomised study (Bye and Elind 1986). Thirteen
patients from the Norwegian Radium Hospital (NRH) were included in the
study and the results showed that the five patients in the intervention group
had less diarrhoea and used less anti-diarrhoeal agents than the control
patients used. These findings were regarded as promising and since
nutrition management guidelines for radiation enteritis were lacking in the
literature, a clinical trial was planned. The purpose was to evaluate the
effects of the diet before it was recommended as standard therapy.
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1.2  Low fat, low lactose diet – theoretical and clinical background
Pelvic radiotherapy is a common treatment modality for patients with
carcinoma of the endometrium or cervix in addition to surgical treatment.
Since parts of the intestine will be located in the field of irradiation,
radiotherapy induces risk of injuries to the small intestine (Donaldson
1984, Yeoh and Horowitz 1987).  Acute injury during radiotherapy is
primarily demonstrated in the epithelial stem cells of the intestinal mucosa
and leads to loss of absorbing surface area and impaired absorption of
nutrients and fluid (Coia, Myerson and Tepper 1995, Letschert 1995). The
patients may experience weight loss and symptoms like nausea, vomiting
and diarrhoea (Thiel, Fietkau and Sauer 1988).
Principles of radiotherapy and effects on healthy tissue
Radiotherapy implies treatment via administration of various forms of
radiant energy.  This energy is transferred to the biological material and
causes cell death (Rassekh and Kennedy 1997, Pachigolla and Pou 2000).
The energy is deposited in atoms or molecules within the cells and this may
result in displacement of an orbital electron or ionisation that may interact
with cellular components. If the interaction is with a critical target within a
cell, irreparable damage occurs (Rassekh and Kennedy 1997). Such a
critical target is most likely DNA. Presumably because radiotherapy
impairs DNA synthesis and interferes with cell replication, rapidly dividing
cells are generally more radiosensitive than slowly dividing cells. The
radiosensitivity of cells varies as a function of the phase of the cell cycle.
The mitotic phase of the cell cycle when DNA is being replicated is
considered relatively more radiosensitive (Pachigolla and Pou 2000). The
shorter time between mitosis the greater is the radiosensitivity. Acute
reactions in healthy tissue during radiotherapy are therefore typically seen
in tissues with high cell turnover rates.
The biologic effects of radiation correlate with the given dose. A bigger
dose leads to a bigger biologic effect and more cell death (Rubin 1989,
Pachigolla and Pou 2000). It is however shown that the therapeutic effects
of radiotherapy are improved if the total dose is administrated in smaller
fractions instead of being given as one single dose (Pachigolla and Pou
2000). During the time intervals between each fraction the tumor cells are
allowed to redistribute into more sensitive phases of the cell cycle which
leads to increased tumor killing. A reoxygenation of the tumor cells also
occurs during these time intervals (Rassekh and Kennedy 1997).  This is
URN:NBN:no-2118
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important since presence of oxygen results in increased tumor cell
senistivity. Fractionated radiotherapy is also applied in order to minimise
complications from healthy tissue (Rubin 1989, Rassekh and Kennedy
1997, Pachigolla and Pou 2000). During the time intervals between each
fraction the normal cells have a possibility to repair injury and regenerate.
The volume irradiated and the localisation of the tumor are of importance
for the reactions to radiation in normal tissue and organs (Thiel, Fietkau
and Sauer 1988, Rubin 1989, Letschert et al 1994). Volume effects are
important in radiotherapy, with the whole organ versus a portion of the
organ being irradiated and with large versus small tumors being irradiated.
Other variables that may affect an organ's response to radiation are
individual patient factors such as diabetes and hypertension, surgery,
trauma, chemotherapy, hyperthermia, and biological response modifiers
(Rubin 1989).  The individual patient variables can decrease vascular flow
and increase the chance of radiation injury.
The radiosensitivity of the small intestine and acute radiation injury
The small intestine has a rapidly reproducing cell population and is
therefore very radiosensitive (Vander, Sherman and Luciano 1994).
Normally the epithelial cells of the small intestine are completely replaced
in 3-6 days. The intestinal mucosa is highly folded and the surface of these
folds has microscopic finger-like projections of the mucosal lining known
as villi. Each villi is about 0.5 to 1.5 mm in length and covered with a
single layer of epithelial cells whose surface membranes form small
projections known as microvilli. The villi are responsible for absorption of
nutrients and greatly increase the effective absorptive surface area of the
small intestine. Every 24-hour there is a cell division in the base of villi
(the crypt of Lieberkühn) (Vander, Sherman and Luciano 1994). The crypt
is the site of stem cell proliferation. The differentiated cells move upwards
and are shed 3-5 days later at the tips of the villi. In a steady state, cell
extrusion from the tips of the villi equals the cell replication rate in the
crypt.  During the course of radiotherapy a progressive shortening of villi is
seen and the total epithelial surface and the thickness of mucosa decreases
(Trier and Browning 1966, Berthrong and Fajardo 1981, Yeoh and
Horowitz 1987). The reason for these effects seems to be interference with
and reduction of the cell replication in the crypts of Lieberkühn. Despite
this interference the migration of cells from the crypt to the villi does not
stop (Thiel, Fietkau and Sauer 1988). This leads to loss of cells and
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impaired replacement of epithelial cells. The loss of tissue function is
thought to occur as a function of the total number of cells lost.
Important in determining the effects of abdominal radiation on the small
intestine is the mobility of the small intestine, which may protect any one
area from receiving a critically high dose.  The intestine is mobile except
the entire duodenum, upper jejunum and terminal ileum. Therefore terminal
ileum is the portions of the small intestine most often at risk of injury from
pelvic radiotherapy together with parts of colon like rectum and sigmoid
colon (Berthrong and Fajardo 1981, Yeoh et al 1993A).
Symptoms of acute radiation enteritis are reported to occur in 50% to 80%
of patients undergoing pelvic radiation (Yeoh and Horowitz 1987, Resbeut
et al 1997). It is indicated that acute reactions from the small intestine are
frequent at total doses above 45 Gy but uncommon below 40 Gy
(Letschert et al 1994) and that the intensity of reactions varies with number
of fractions and dose per fraction. The acute effects are generally reversible
and the symptoms are usually of limited duration and cease within six
weeks after completion of treatment (Yeoh and Horowitz 1987).
Late effects of radiotherapy
Acute radiation reactions may recur as late radiation enteritis clinically
characterised by diarrhoea and abdominal cramps (Danielsson et al 1991,
Coia, Myerson and Tepper 1995). Late radiation complications usually
appear six to 24 months after treatment, but can also occur at any time
during the lifetime of the patient (Kinsella and Bloomer 1980, Berthrong
and Fajardo 1981, Yeoh and Horowitz 1987, Danielsson et al 1991, Coia,
Myerson and Tepper 1995).  In contrast to acute injury that primarily is
demonstrated in the mucosa, late effects seem to be associated with effect
throughout the bowel wall (Danielsson et al 1991, Coia, Myerson and
Tepper 1995, Letschert 1995). Retrospective studies suggest an incidence
of severe complications in 5-15% of the patients (Yeoh and Horowitz 1987,
Letschert 1995,). Common symptoms are intestinal obstruction, mucosal
ulceration, perforation, chronic blood loss and severe inflammation of the
rectum and colon. The late effects are often irreversible and impaired
intestinal absorption of nutrients is common. For this reason the late effects
tend to interfere with the nutritional status to a higher extent than the acute
ones. Obstruction, fistula formation, or strictures may further contribute to
the general malabsorption (Coia, Myerson and Tepper 1995).
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The relationship between occurrence of an early effect and likelihood of
developing a late effect is not well understood. With high doses or in
locally attached immobile intestinal loops, recovery after radiation may be
incomplete with persistence of villi atrophy and abnormal, stunted or cystic
crypts (Berthrong and Fajardo 1981). It seems like the risk of developing
significant chronic radiation enteritis increases with the severity of acute
radiation syndrome. On the other hand, absence of acute enteritis does not
seem to exclude late injuries (Bourne et al 1983). Previous abdominal
surgery, concurrent chemotherapy and pelvic inflammatory disease may be
risk factors in the development of severe chronic radiation injury possibly
because of adhesions (Yeoh and Horowitz 1987, Coia, Myerson and Tepper
1995).
Impaired absorption and diarrhoea
Clinical studies conducted to evaluate the effect of radiotherapy on
absorption are presented in table 1-1. Impaired absorption of bile acids, fat
and lactose are most frequently reported, but also impaired absorption of
proteins is seen.
Impaired absorption of bile acid and fats
Impaired bile acid absorption is demonstrated in the majority of studies
evaluating intestinal absorption during radiotherapy (Jackson and
Entenman 1959, Sullivan 1962, Sullivan 1965, Morgenstern and Hiatt
1967, Stryker, Hepner and Mortel 1977, Stryker and Demers 1979, Yeoh,
Lui and Lee 1984, Ruppin et al 1987, Fernandez-Banares et al 1991, Yeoh
et al 1993A). Impairment of bile acid absorption seems to drop gradually
during radiotherapy reaching the lowest level the last week of treatment
which is the period of worst diarrhoea (Stryker, Hepner and Mortel 1977,
Stryker andDemers 1979, Ruppin 1987). A net loss of bile acids may occur
and gradually lead to fat malabsorption (Merrick 1988). A high faecal fat
has been shown to correlate with diarrhoea during radiotherapy (Reeves et
al 1965).
URN:NBN:no-2118
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Most of the fat found in food is in form of triacylglycerol, which are
insoluble in water (Vander, Sherman and Luciano 1994). The function of
bile salts is to break up large fat droplets and form water-soluble particles,
which makes it possible for the enzyme lipase to break down
triacylglycerols. The result is free fatty acids, mono- and diglycerides,
which form micelles together with cholesterol, bile acids and fat soluble
vitamins. Fatty acids, monoglycerides, cholesterol and vitamins are
absorbed across the cell membrane by simple diffusion. Short and medium
chain fatty acids are more water soluble and not dependent on bile to be
absorbed.
Normally 95 % or more of secreted bile salts are reabsorbed by the ileum to
be used again in digestion (Merrick 1988). The body has a pool of 2-3 g of
bile salts (Eusufzai 1995). A fat intake of about 100-g induces an excretion
of 30-g bile salts per day. This is much more than the liver is able to
produce but because of reabsorption of bile salts this is possible. It is
generally accepted that bile salts are actively absorbed from the terminal
ileum, and that the absorption from jejunum and colon is by means of
passive diffusion (Merrick 1988, Eusufzai 1995).
The reason for impaired absorption of bile acids during radiotherapy may
be damage to the terminal ileum. If intestinal mucosa is injured or inflamed
bile acids are not reabsorebed adequately and a break in the enterohepatic
circulation occurs (Merrick 1988). Because of its location and immobility
the terminal ileum is the portions of the small intestine most often at risk of
injury from pelvic radiotherapy (Berthrong and Fajardo 1981, Yeoh et al
1993A).  Impaired bile acid absorption may also occur as a result of
increased transit through the gut (Eusufzai 1995). Increased transit through
the intestine has been demonstrated in several studies (Yeoh, Lui and Lee
1984, Fernandez-Banares et al 1991, Yeoh et al 1993A). The small
intestine heals rapidly after radiotherapy and after two to three weeks
mucosa appears normal. It may however last longer before the absorption
of bile acid normalise. Studies have indicated about three months (Stryker,
Hepner and Mortel 1977).
Diarrhoea caused by impaired bile acid absorption
Any diarrhoea is characterised by increased water content in faeces, which
is caused either by decreased fluid absorption or increased fluid secretion
(Vander, Sherman and Luciano 1994). The presence of unabsorbed solutes
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in the lumen, as a result of decreased digestion or absorption, also results in
retained fluid and diarrhoea.
The membranes of the epithelial cells are very permeable to water (Vander,
Sherman and Luciano 1994). Therefore a net diffusion of water (osmosis)
occurs across the epithelium whenever a water concentration gradient is
established as a result of differences in the total solute concentration
(osmolarity) on the two sides. Active solute transport establishes the
osmotic gradient leading to a net movement of water. The net absorption of
water has an important effect upon the absorption of other substances
which cross the epithelium by simple diffusion. As water is absorbed the
volume of the luminal contents decreases, thereby concentrating any
solutes not absorbed at the same rate. This rise in concentration secondary
to water reabsorption provides the concentration gradient for the net
diffusion of these substances across the intestinal wall. If the necessary
concentration gradient is not established, water remains in the gut and the
loose bowel movement occur. Diarrhoea is normally accompanied by an
increased frequency of bowel movements because of increased motility in
the colon (Vander, Sherman and Luciano 1994). Diarrhoea without an
increase in bowel movements is also seen (Sölvell 1981).
A break in the enterohepatic circulation may lead to excess bile salts in the
colon (Arlow 1987). Dihydroxy bile salts have a direct effect on the rate of
sodium absorption and colonic secretion and cause diarrhoea when they are
present in the colon in abnormally high concentrations (Merrick 1988).
Deficiency of dihydroxy bile salts on the other hand results in constipation.
The diarrhoea is typically most severe in the morning, painless or
accompanied by discomfort relieved by evacuation, watery and commonly
provoked by eating (Merrick 1988).
Steatorrhoea
Increased faecal loss of bile salts is normally balanced by increased
synthesis of bile salts from cholesterol in the liver (Merrick 1988, Mekhjian
et al 1971).  If the losses are small it is possible to maintain the body pool.
A further decrease in reabsorption will make it difficult for the liver to
replace the losses through increased production (Eusufzai 1995). After a
while a total loss of bile acids may occur which affect the micelle formation
and thereby the fat digestion, and steatorrhoea may develop (Andersson et
al 1986). Unabsorbed fatty acids have no osmotic effect on the intestine but
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bacterial organisms in the colon transform them to compounds that reduce
salt and water absorption (Andersson et al 1986, Hessov and Ovesen 1995).
Steatorrhoea is characterised by large amounts of unabsorbed dietary fat
and increased faecal volume (Dotevall and Gillberg 1981). The bowel
movements are greasy, light in colour and may be difficult to flush
(Rönnlund, Sandahl and Hardell 1985).
Steatorrhoea may lead to decreased absorption of fat-soluble vitamins
(Hessov and Ovesen 1995). Fat-soluble vitamins form micelles together
with free fatty acids and bile acids. Any interference with the secretion of
bile or action of bile salts in the intestine will therefore also affect the
absorption of fat-soluble vitamins. The amount of fat-soluble vitamins
stored in the body is however quite big and it will take a while before
symptoms of depletion develop. Vitamin K is excepted from this because
the stores are emptied 2-3 after the onset of decreased absorption.
Magnesium and calcium may form complexes with free fatty acids that are
not absorbable (Andersson et al 1986, Hessov and Ovesen 1995).
Deficiency of magnesium may develop as a result of diarrhoea. Among
patients with steatorrhoea it is seen an increased excretion of magnesium
when the intake of fat increases. The extent of magnesium deficiency
seems to be associated with the extent of fat malabsorption and volume of
bowel movements. It is also shown that patients with steatorrhoea excrete
high amount of oxalate in the urine. If the diet is high in oxalate these
patients have a tendency to develop renal stones (Eusufzai 1995). Normally
the dietary oxalate reacts with calcium in the intestine. Calcium oxalate is
formed and excreted with the stools. Steatorrhoea may cause the calcium to
react with free fatty acids instead and oxalate is absorbed to a greater
extent. In the kidneys the increased oxalate may lead to formation of renal
stones. A low fat diet seems to increase the absorption of calcium and
magnesium among patients with steatorrhoea and may prevent the
formation of stones and magnesium deficiency (Andersson et al 1986).
Impaired absorption of lactose
Disaccharides like sucrose and lactose have to be split in two
monosaccharides before absorption (Vander, Sherman and Luciano 1994).
The enzymes are located in the plasma membranes of the epithelial cells.
Reductions in the activity of disaccharidases have been demonstrated
during radiotherapy (Stryker, Mortel and Hepner 1978, Beer, Fan and
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Halsted 1985). The ability to digest lactose seems to be especially affected.
In one study conducted to evaluate the function of intestine during
radiotherapy it was found that six out of eight patients had low lactase
activity while three had low sucrase activity (Beer, Fan and Halsted 1985).
Stryker, Mortel and Hepner (1978) suggested that radiotherapy to pelvis
and abdomen lead to a significant reduction in the ability to absorb lactose.
They found that 12 of 24 patients had abnormal 14C lactose breath tests
during the fifth week of radiotherapy. There was a significant correlation
between bowel movements and the degree of impaired lactose absorption
and between nausea and impaired lactose absorption.
Diarrhoea caused by impaired lactose absorption
The diarrhoea associated with lactase deficiency is a consequence of
diminished fluid absorption in small intestine and fluid secretion into colon
(Dotevall and Gillberg 1981).   When the enzyme lactase is absent in the
intestinal epithelium, lactose can not be absorbed. Lactose remains in the
lumen of small intestine where it prevents water absorption (Vander,
Sherman and Luciano 1994). The unabsorbed lactose containing fluid is
passed on to the large intestine. Here bacteria, which do have the enzymes
capable of metabolising lactose, produce large quantities of gas and organic
products, which inhibits active-transport processes and increase osmolarity.
The result is an accumulation of fluid in the lumen of large intestine.
Possible symptoms of lactose intolerance include abdominal pain, bloating,
gas/flatulence, and diarrhoea (McBean and Miller 1998). The severity of
symptoms varies with the amount of lactose and conditions under which
lactose is consumed and the ability of the patient to tolerate the lactose load
(Vander, Sherman and Luciano 1994). In general the symptoms and
tolerance to lactose are highly individual. It is shown that lactose
maldigesters may tolerate up to 6-g lactose when consumed in water after
an overnight fast (Hertzler, Huynh and Savaiano 1996). Greater amounts
may however, induce severe symptoms. However, it is suggested that
lactose doses of 12 g or more may be well tolerated if consumed with other
foods. Onset of symptoms is anywhere between 30 minutes and several
hours after consuming lactose-containing foods and beverages
(McBean and Miller 1998).
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Symptomatic treatment of radiation induced diarrhoea
Randomised clinical trials conducted to evaluate effect of bile acid binding
drugs or diet on diarrhoea during radiotherapy are shown in table 1-2.
Bile acid sequestering resins
In small, not controlled studies, bile acid sequestering resins have been
effective in the treatment of bile salt malabsorption (Heusinkveld, Manning
and Aristizbal 1978, Condon et al 1978). Cholestyramine is an anion
exchange resin that forms insoluble complexes with bile acids
(Heusinkveld, Manning and Aristizbal 1978). By sequestering bile acids
through binding, the effect of excess bile salts on the colonic mucosa may
be prevented and thereby the diarrhoea. Clinical trials have shown that
Cholestyramine may induce side effects like nausea and abdominal cramps
(Chary and Thomson 1984). By many of the patients Cholestyramine was
considered to be unpalatable and they were reluctant to eat it.  Despite this
the effect on diarrhoea was good. But because of the side effects,
cholestyramine was not recommended for all patients undergoing
radiotherapy (Chary and Thomson 1984). Both study groups were
receiving a low fat diet from start of radiotherapy. The diet seemed to
prevent diarrhoea and the patients had no problems to eat it. The authors
recommended that the low fat diet should be used as a routine during
radiotherapy. Cholestyramine could be offered to those patients not
obtaining a control of the diarrhoea with the diet. One other problem with
Cholestyramine may be that it frequently is not possible to maintain a
comfortable balance between diarrhoea and constipation (Merrick 1988).
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Colestipol hydrochloride is another bile acid sequestering agent. This drug
is not shown to bee as effective as cholestyramine (Stryker, Chung and
Layser 1983). Colestipol was not well accepted by the patients since it was
associated with considerable side effects like nausea, vomiting and
abdominal cramps. There was no difference in weekly bowel movement
frequency between the colestipol and the control group but the colestipol
patients who took at least 50% of the prescribed dose required less
antidiarrhoeal medication. It was concluded that colestipol hydrochloride is
not of value in preventing radiation-induced diarrhoea because of its side
effects but the theory on which the use of bile acid sequestering agents is
based may be correct.
Low fat diet
In patients with impaired fat absorption a low fat diet (maximum 40-g of
fat per day) seems to reduce the faecal bile salt excretion and thus the
diarrhoea (Small, Dowling and Redinger 1972, Andersson et al 1973,
Andersson, Isaksson and Sjögren 1974, Andersson 1976).  When the fat
content in the diet decreases, the amount of bile salts needed to emulgate
the fat also decreases. The exact amount of fat that can be tolerated per day
in the case of fat malabsorption is not clear. It is claimed that it is enough to
reduce the intake of fat to 25% of the total energy content, which
corresponds to 50-60 g of fat per day (Hessov and Ovesen 1995).  The
tolerance seems to depend on the degree of bile salt/fat malabsorption.  It is
presumed that less fat in the diet reduce emptying of the gall bladder.
Patients who have a normally functioning gall bladder therefor have the
best effect of a low fat diet (Andersson et al 1986). A higher net absorption
of calcium, magnesium and zinc might be another positive effect of a low
fat diet in patients with impaired fat absorption (Hessov, Andersson and
Isaksson 1983).
Patients with diarrhoea and impaired bile acid absorption after pelvic
radiotherapy have been treated with a low fat diet (40 g of fat per day) for 3
to 6 months (Bosaeus, Andersson and Nyström 1979). In eight of nine
patients the faecal excretion of bile salts decreased concomitant with relief
of symptoms. The 9th patient had no gall bladder but the diarrhoea ceased
after treatment with cholestyramine.
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Low lactose diet
Impaired lactose absorption is best corrected by removing the disaccharide
from the diet by restricting the intake of milk (Hertzler, Huynh and
Savaiano 1996). It is not shown that a lactose-restricted diet can prevent
radiation-induced diarrhoea. In one study 64 patients were randomised
prior to pelvic radiotherapy into one of three groups: lactose-restricted diet,
hydrolysed lactose and control (Stryker and Bartholomew 1986). No
statistically significant differences between the three groups were found.
The group receiving hydrolysed lactose even seemed to have some more
diarrhoea than the control group. They explained this finding by claiming
that the low values of 14 CO2 earlier found in breath tests (Stryker, Mortel
and Hepner 1978) were misinterpreted. Delayed emptying of the stomach
because of nausea and medication may have lead to the same result on the
breath tests, as impaired lactose absorption would have done (Stryker and
Bartholomew 1986). However, impaired lactose absorption was not
excluded as a possibility for the diarrhoea, but they concluded that this
could not be the most important cause of diarrhoea during radiotherapy.  In
addition it is known that impaired lactose absorption may come secondary
to all diarrhoea (Statens ernæringsråd 1995).
Terminal ileum is the part of small intestine that receives the highest dose
during pelvic radiotherapy (Wellwood and Jackson 1973, Stryker and
Demers 1979). Lactose, however, seem to be absorbed during the first 20%
of the intestine (Vander, Sherman and Luciano 1994). When the intestinal
content reaches the terminal ileum almost all the lactose is absorbed in
most patients.  It is shown that the amount of small intestine included in the
treatment volume influence the degree of impaired lactose absorption
(Weiss and Stryker 1982). 14C lactose breath tests were performed on two
groups where the amount of small intestine included in the treatment
volume differed. The results showed a higher degree of impaired lactose
absorption when a significant portion of the intestine was included in the
treatment volume.
Dietary management of acute radiation enteritis
Several studies have demonstrated that impaired bile salt absorption is a
factor in the aetiology of acute radiation diarrhoea during pelvic
radiotherapy. Impaired lactose absorption also seems to be a factor, but the
volume of small intestine included in the treatment field seems to influence
the degree of impairment. A low fat diet, 40 g of fat, is indicated to prevent
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diarrhoea caused by impaired bile salt absorption (Bosaeus, Andersson and
Nyström 1979).  Lactose maldigesters may tolerate up to 6-g lactose in one
meal without having diarrhoea (Hertzler, Huynh and Savaiano 1996). This
indicates that a low fat, low lactose diet could prevent diarrhoea during
pelvic radiotherapy. The diet should be used from the first day of
radiotherapy since cell-replication in the intestinal mucosa is affected from
the start of treatment (Berthrong and Fajardo 1981). It is reported that the
intestinal mucosa is normally healed two to three weeks after end of
radiotherapy (Trier and Browning 1966, Berthrong and Fajardo 1981). Also
during the healing process the diet should be low in fat and lactose.
1.3  Nutritional support and health related quality of life
Like in all other medical research it has been common to consider the effect
of nutritional support on a narrow set of outcome variables like
improvement of nutritional status or survival. Efforts to treat malnutrition
or to improve survival or treatment toxicity with nutritional support in
cancer patients, have mostly failed (Cella et al 1993). Such studies might
have been be enriched if improvement in mobility, work function, mood
state or social relationships had been used as outcome measures (Cella et al
1993).  These additional benefits can be included in the concept health
related quality of life (HRQOL).
Diet and HRQOL in cancer patients
Observations of improved well-being and symptom control have been
made in connection with nutritional support and one may easily imagine
that nutritional problems and deteriorated nutritional status may affect
HRQOL negatively. Anorexia and weight loss may lead to depletion of
energy stores as well as a catabolic state that results in fatigue and bodily
discomfort (Tchekmedyian, Cella and Heber 1999). Anorexia may also
have social implications since meals are important opportunities for the
family to be together.
Most studies on diet and HRQOL have focused on how malnutrion in
cancer patients may affect quality of life domains like psychological
distress or depression (Bruera et al 1984, Westin et al 1988, Ovesen,
Hannibal and Mortensen 1993). Most of these studies show an association,
but it has not been possible to determine whether depression causes
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malnutrition or develops as a consequence of it (Bruera et al 1984).
Bruning et al (1985) showed no association between, what they called
mental fitness, and dietary intake. They did however find that malaise had a
clear inverse relationship with food intake, but again it was not possible to
determine what came first, diminished intake or malaise. Others have found
that loss of appetite may be an important determinant in the general well
being aspect of HRQOL during treatment (Coates et al 1983, Macuart-
Moulin et al 1999).
The instruments used to measure psychological distress in these studies
vary. The investigators have often used small sets of questions developed
for the given study without any systematic approach. This makes it difficult
to make a direct comparison between the studies. In a study from
Hammerlid et al (1998) a more systematic approach was chosen as they
used a cancer specific instrument that was validated and used in several
other studies (Aaronson et al 1993). The study from Hammerlid et al
(1998) focused on how malnutrition affected physical functioning and
symptoms. In a group of head and neck cancer they found no strong
association between malnutrition and functioning or symptoms. The
malnourished patients scored lower than the patients with normal
nutritional status on most symptoms/functions, but the differences were not
statistically significant. At the 2-year follow-up the survivors scored
significant better than the deceased for appetite loss, swallowing difficulties
and global quality of life. Although the groups were small, the authors
concluded that measurement of HRQOL might be of prognostic value.
Despite these results showing that malnutrition might affect well being and
functioning negatively, we have been able to find only one dietary
intervention study in cancer patients that have used HRQOL as a primary
outcome measure.  Nutritional counselling was given to a group of patients
undergoing chemotherapy for various cancers (Ovesen et al 1993). The
counselled group increased the energy and protein intake but no statistical
differences were found between the two groups after two months with
respect to weight gain. Clinical benefits could not be demonstrated on
survival, tumor response or measurement of QOL. The Quality of Life
index (QL-index) (Spitzer et al 1981) which was rated by the patients was
used to assess QOL.  This index has been criticised for not capturing
information about the different dimensions of QOL and the fact that each
question asks about more than one aspect (Maguire and Selby 1989).
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Measurement of HRQOL
In the present study we did not expect that nutritional support during
radiotherapy would improve survival, but we assumed that absence or
presence of diarrhoea could influence the patients' physical symptoms and
functional status. To assess such outcomes of the diet intervention a
questionnaire developed by the European Organisation for Research and
Treatment of Cancer (EORTC) was used (Aaronson et al 1991). The term
HRQOL was defined as the patients' self-reported subjective physical and
psychosocial situation as a consequence of disease and treatment. When the
present study started one of the first randomised trials including HRQOL-
measurements in oncology was already performed at NRH by Kaasa,
Mastekaasa and Naess (1988).
In 1980, a study group on Quality of Life was created within the EORTC
with the long-term goal of developing a brief standardised QoL measure to
be used internationally in cancer trials. The multinational effort resulted in
a self-assessment core questionnaire that is multidimensional, cancer
specific and cross-culturally validated (Aaronson, Bullinger and Ahmedzai
1988, Aaronson et al  1991, Aaronson et al 1993). In this approach a core
of general items are given to all patients. This provides standardised
assessment for comparison across disease, symptoms and treatments or
with normal population (Kaasa 1992).
HRQOL is not used as a single entity but defined as a multidimensional
health related construct including physical, social and mental dimensions
(Aaronson, Bullinger and Ahmedzai 1988). The dimensions in HRQOL are
further divided into sub-dimensions such as physical functioning, role
functioning, emotional functioning, well being, fatigue etc. The core
questionnaire is supplemented with illness- and treatment specific items.
The general items are developed and standardised prior to the study and the
investigators develop the specific items. These specific items are based on
particular areas of interest implicated by the new intervention tested. This
approach provides specific information about problems unique to the
patient group under study.
The original questionnaire contained 42 items, which were subsequently
reduced to 36. The 36-item version was widely tested and validated
(Aaronson et al 1991).  These 36 items have been shortened down to 30
(QLQ-C30) which is the current recommended version (Aaronson et al
1993). There are also 13 supplementary disease-specific modules, for
URN:NBN:no-2118
34
example for lung cancer, breast cancer and head and neck cancer
(Aaronson, Bullinger and Ahmedzai 1988, Bjordal and Kaasa 1992).  The
questionnaire is under constant development. As an example is a work in
progress were the aim is to reduce the QLQ-C30 from 30 to approximately
20 items to make it more suitable for palliative care patients (Groenvold,
Petersen and Bjorner 2000). The shortened version will be comparable with
the original version and is expected to ready by the end of year 2001.
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1.4 Aims and research questions
The aim of the present study was to evaluate the effect of a low fat, low
lactose diet on acute and late gastrointestinal side effects of pelvic
radiotherapy.
The following study questions were formulated:
x Does a low fat diet affect the intake of vitamins?
x Does the study groups comply with their diets?
x Does a low fat, low lactose diet during pelvic radiotherapy reduce acute
diarrhoea?
x Does low fat diet lead to reduced energy intake?
x Does diet interventions during pelvic radiotherapy influence the patients
health related quality of life?
x Does a low fat, low lactose diet during pelvic radiotherapy reduce late
radiation injury and chronic diarrhoea?
The study hypothesises were as follows:
 Patients, who restrict the fat intake to 40 g per day (intervention group)
have a lower intake of fat-soluble vitamins and a higher intake of water-
soluble vitamins as compared to patients receiving regular hospital diet
(control group). (Paper I)
 Dietary counselling leads to a lower intake of fat in the intervention
group as compared with the control group during radiotherapy and six
weeks after end of therapy. (Paper II)
 Patients, who restrict the fat intake to 40 g per day and the lactose intake
to 5 g per meal (intervention group) during pelvic radiotherapy, have less
 diarrhoea during treatment than patients receiving regular hospital diet
(control group). (Paper III)
 Low fat, low lactose diet during radiotherapy will contribute to
maintenance of good nutritional status. (Paper IV)
 Presence of diarrhoea during radiotherapy reduce patients self-reported
health-related quality of life. (Paper V)
 Patients, who eat a low fat, low lactose diet during pelvic radiotherapy
(intervention group), are less likely to develop late radiation injury and
chronic diarrhoea as compared to patients receiving regular hospital
diet. (control group). (Paper VI)
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 2. Material and methods
 
 Table 2-1 gives an overview of the methods used in the papers.
 
 
 Table 2-1 Overview of the methods used in the study
 
  
 Paper
 I
 
 Paper
 II
 
 Paper
III
 
 Paper
IV
 
 Paper
 V
 
 Paper
VI
 Frequency of bowel movements    X  X  X  X
 Nutritional status
 - weight
 - body mass index
 - arm circumference
 - biochemical indicators
 
 
 
 
 
 
 X
 
 
 X
 
 X
 X
 
 X
 
 X
 X
  
 
 X
 Health related QoL      X  X
 Dietary intake
 -  48-hour recall
 -  4-days food record
 by household measures
  - 7-days weighed food record
 
 X
 X
 
 
 X
 
 X
 X
 
 X
 X
 
 X
  
 Validation of diatary intake
 - 24-hour urinary nitrogen
 - physical activity level
 - weight development
  
 X
 X
 X
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 2.1 Design and study population
 The study was designed as an open randomised clinical trial and conducted
at NRH. Inclusion and randomisation were performed 1-2 days prior to
radiotherapy.  After the decision on treatment by the oncologists the
eligible women were approached and asked to participate. AB (main
author) did all contacts. If the patients accepted to participate they were
immediately randomised to intervention or control group. Dietary treatment
and radiotherapy started simultaneously. The diet was to be followed
during radiotherapy and six weeks after the end of radiotherapy.
Measurements were performed prior to radiotherapy, the 3rd and last week
of radiotherapy, 6 weeks after end of radiotherapy and then every eight-
week. The follow up period was one year (figure 2-1). In November 1993
the surviving patients were approached once more and asked to complete a
questionnaire package similar to the one completed during the clinical trial.
The response rates (respondents in percent of total eligible patients) are
described in 3333 2-2.
 
 Table 2-2  Response rates (respondents in percent of total eligible patients)
 
  
 Eligible
 Declined to
participate
 
 Respondents
 
 Response rate
%
 Clinical study  183  40  143  78
 Survivors  941  15  79  84
 
 1 Those who declined participation were not included among those regarded as eligible
in the follow-up study
 
 
 The study population was recruited from the department of gynaecology at
NRH. Criteria for selection and exclusion are described in detail in paper
III. The main selection criteria were external pelvic radiotherapy to a total
dose above 40 Gy, age equal to or less then 75 years and a WHO functional
status (WHO 1979) better than or equal to 2. The women were not
considered eligible if they previously had received chemotherapy or if
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 Figure 2-1 Study design
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 surgery were planned after radiotherapy. Women with a diagnosed
inflammatory bowel disease or resection of the intestine were also
excluded.
 
 Patients were consecutive included from May 1988 through May 1990.
During this period a total of 183 women were eligible and invited to
participate, 143 (78%) accepted.  Seventy-one were assigned to the
intervention diet and 72 to the control group. In November 1993 the
women, who did not withdraw during the first year of follow-up, were alive
and without known relapse were approached. According to the Population
Register of Norway and the hospital files 94 women were alive and without
known relapse; 79 (84%) accepted participation. Drop-off in participation
from inclusion and during follows up is shown in figure 2-2 and 2-3.
Details about the patients' age, social status and treatment regimens are
reported in paper III, IV, V and VI.
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 Intervention group  Control group
 
Decline: 1
No answer : 1
Declined : 6
No answer : 2
Declined: 2
No answer : 3
Declined: 1
No answer : 3
Recurrence/death : 1
No answer: 2
Recurrence/death : 2
No answer: 3
Declined: 0
No answer : 1
Recurrence/death : 2
Declined: 1
No answer : 1
One year
n=58
46th week
n=58
38th week
n=60
30th week
n=61
22nd week
n=62
Weeks after start: 12
n=64
Weeks after start: 6
n=70
Included
Baseline
n=71
 
Decline: 3
No answer : 0
Declined : 1
No answer : 0
Declined: 1
No answer : 0
Declined: 1
No answer : 5
Recurrence/death : 1
Declined: 2
No answer: 6
Decline : 0
No answer : 5
Recurrence/death : 2
No answer : 3
Recurrence/death : 2
No answer : 3
One year
n=61
46th week
n=63
38th week
n=63
30th week
n=66
22nd week
n=67
Weeks after start: 12
n=68
Weeks after start: 6
n=69
Included
Baseline
n=72
 
 Figure 2-2. Drop-off in participation during the clinical study
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 Intervention group  Control group
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Recurrence : 0
Recurrence : 1
No answer : 5
Unknown address: 1
3-4 years after start
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n=50
Completed
the clinical study
n=55
 
Death : 12
Recurrence : 3
Other disease : 1
No answer : 6
Unknown address: 1
3-4 years after start
sendt
n=44
Completed
the clinical study
n=59
 
 Figure 2-3  Drop-off in participation at 3-4 years follow-up
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 2.2 The intervention diet
 The intervention diet is described in paper I and III.  The average fat content
in the regular hospital diet was 80 g (44% of energy from fat).  To obtain the
intervention diet with maximum 40 g fat per day, low fat milk products, lean
meat and fish were used. The energy lost by reducing the fat was about 1.5
MJ and it was important to replace this energy to prevent weight reduction.
The energy was replaced by increasing the amounts of foods with
carbohydrates (bread, vegetables, and fruit). As a consequence of this the
volume of the diet increased.  Four slices of bread equals about 1.5 MJ.
Patients in both groups were advised to eat enough to maintain weight during
radiotherapy and to use nutritional supplements if necessary.
 
 The hospital kitchen planned the intervention diet in co-operation with the
dietician. Both the intervention diet and the regular diet were composed to
match the recommendations for daily intake of nutrients and produced in
accordance with the Norwegian Guidelines for Hospital Diets (Statens
ernæringsråd 1985).
 
 2.3 Dietary advises – intervention group
 In order to secure the patients compliance to the diet individual advice on the
type and quantity of foods to eat were given. Initially the women were asked
what they usually ate. Based on this information the individual advises were
formulated. Women reporting use of margarine or butter on the bread were
advised to replace this with low fat alternatives or to stop using it. If milk
intake was reported they were advised to restrict the intake of milk to the
meals, no more than one glass (150-ml) at the time and not exceed three
glasses of milk daily. Folders with information about low fat cooking and
foods were produced and handed out to the women.
 
 The counselling made it possible for the patients to keep the diet when they
had food in addition to the hospital meals or were outside the hospital.  It was
also necessary for the outpatients who had to prepare the low fat, low lactose
diet themselves. Thorough knowledge of low fat foods and cooking methods
was considered important for compliance. Dietary habits are closely linked to
the culture and changes in dietary intake may have consequences for the
normal daily living. It may especially be difficult to keep to a diet at social
gatherings.  It was therefore reckoned important not to make more changes to
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the women's diet than necessary and the intervention diet was planned as
similar to the regular diet as possible.
 
 During the hospital stay (approximately six weeks), AB had daily contact
with the women. They were asked about their satisfaction with the diet and
the dietary advises were repeated when necessary. Before they left the
hospital the dietary advises were repeated and further information was given
if necessary. During the next six weeks the women followed the diet at home.
No systematic dietary follow-up was scheduled but the women were free to
call (AB) if they had any questions.
 
 
 2.4 Effect variables
 Frequency of bowel movements
 The women registered the daily number and consistency of bowel
movements. The data was categorised according to table 2-3 and used to
evaluate if diarrhoea was present or not.  The method is described in detail in
paper III and VI.
 
 
 Table 2-3 Categorisation of diarrhoea
 
 0 - no change in bowel movements
 1 - increase of 1-3 bowel movements a day, normal or soft
 2 - increase of 4-6 bowel movements a day, all watery bowel movements
 3 - increase of > 6 bowel movements a day
 
 
 Loperamide was used as standard treatment of radiation induced diarrhoea.
This medicament is an opiate agonist precursor, which seem to slow down
small intestine transit and increase bile acid absorption (Yeoh et al 1993B).
Patients in both groups were instructed to take the medicataion when they felt
it was necessary and to register the number of tablets taken.
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 Nutritional status
 Nutritional assessment may be performed longitudinally by measuring
changes in response to dietary interventions. The basic methods used in
clinical practise to evaluate nutritional status may be grouped into four types
of activities; anthropometrics, biochemical tests, clinical observations and
dietary and personal histories (Williams 1995A). Assessment of nutritional
status can be defined as the interpretation of this information and the
evaluation is usually performed by a combination of the different methods.
Because no single parameter alone directly measures nutritional status each
part of this approach is important.
 
 In this study it was chosen to evaluate nutritional status according to a
protocol by Blackburn (Blackburn et al 1977).  Table 2-4 gives a description
of different parameters used in evaluation of nutritional status. The following
anthropometric measures were used:
 - height and weight
 - body mass index, i.e. weight/ (height)2
 - triceps skinfold thickness
 - arm circumference
 
 Biochemical indicators of nutritional status were serum transferrin and serum
albumin. Assessment of dietary intake was evaluated by the means of:
 - 48-hour recall prior to radiotherapy
 - 4-days unweighed dietary record during radiotherapy
 - 7-days weighed dietary records during follow-up
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 Table 2-4  Parameters used to evaluate nutritional status
 
 Parameters  How to measure poor nutrition
 Anthropometrics
 - Weight
 - Body Mass Index (BMI)
 - Mid-Upper-Arm Circumference
(MAC)
 - Triceps Skinfold Thickness
(TSF)
 - Mid-Upper-Arm Muscle
  Circumference (AMC)
 
 Biochemical Tests
  Measures of
  Plasma Protein Compartment
   - Serum albumin
   - Serum transferrin
 
 Measures of Protein Metabolism:
   24-Hour Urine Tests
   - Urinary urea nitrogen
 
 Dietary assessment methods
 - 24-Hour Food record
 - Food records
   4-days unweighed dietary record
   7-days weighed dietary records
 
 Note weight loss
 Compute BMI=kg/m2 , < 20 indicate poor nutrition
 Compare with previous measurements to note change
 
 Compare with previous measurements to note change
 
 Compute AMC (cm)=MAC (cm) - [3.14xTSF(cm)]
 and compare with reference data
 
 
 
 
 Compare with normal range
 Compare with normal range
 
 
 Compare with calculated dietary nitrogen intake to
determine the nitrogen balance
 
 
 Calculate nutrient intake
 
 Calculate nutrient intake
 Calculate nutrient intake
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 Health related Quality of Life (HRQOL)
 HRQOL was defined as the patients' self-reported subjective physical and
psychosocial situation as a consequence of disease and treatment. It was
measured with the EORTC Core Quality of Life Questionnaire 36-item
version (EORTC QLQ-C36) (Aaronson et al 1991) and a module designed for
gynaecological cancer.  The physicians and researchers at the NRH
constructed this ad hoc module for the present study. The EORTC QLQ-C36
version was a result of work in the study group of quality of life of the
EORTC. The first generation core questionnaire was developed in 1987. The
goal of this work was to construct a cancer specific, multidimensional, self-
administered instrument responsive to clinical changes to be used in clinical
trials. The study group evaluated validity and statistical properties. Since the
QLQ-C36 version the questionnaire has been validated and cross-culturally
tested in various cancer populations and translated into 27 languages (Bjordal
and Kaasa 1992, Aaronson et al 1993, Osoba et al 1994, Kaasa et al 1995,
Bjordal et al 2000).  The EORTC QLQ-C30 version 1, existed when the
follow up study was conducted, but it was decided to use the C-36 version to
be able to compare the data longitudinally.
 
 The questionnaire consists of 36 items with dichotomous, four or seven
response categories. Multi-item scales for:
 - physical functioning
 - fatigue/malaise
 - nausea/vomiting
 - role functioning
 - social functioning
 - emotional functioning
 - global health/quality of life
 
 
 Other general cancer symptoms are covered by single items.
 The additional gynaecological cancer module consists of 17 questions. This
module focus on diagnosis specific symptoms, pain and treatment side effects.
 
 In the later versions of the questionnaire the scores are linearly transformed to
a 0 to 100 scale. This was done with the data collected by the QLQ-C36
version in paper IV in order to compare our data with population-based
norms.
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 2.5 Control of the intervention
 Compliance with the diet was evaluated by the means of dietary assessments
methods (table 2-4). Detailed description of the methods are given in paper I,
V and VI.
 
 Three methods were applied and the choice of methods was partly dictated of
practical conditions and the study design. Since the study design was
prospective, use of food records was preferred (prospective methods). Dietary
treatment started the very same day or the day after inclusion. It was also
possible that the patients had been fasting during the 24 hours prior to
inclusion. These facts made it impossible use prospective methods to obtain
baseline information and instead a retrospective method (48-hour recall) was
used (Callmer et al 1986).
 
 During radiotherapy a 4-days food record by household measures was used to
assess dietary intake (Kuskowska-Wolk 1990). Most of the patients got the
diet from the hospital kitchen and it was standardised with respect to portion
sizes and composition. Because of this it was assumed that it was not
necessary for the patients to weigh everything they ate. To provide weights
for calculation of dietary intake extra portions of the low fat, low lactose diet
and of the regular hospital diet were ordered from the kitchen to a non-
existing patient. AB weighed these portions.
 
 During the follow-up a 7-days weighed food record was used because day-to-
day variation in the intake of fat was expected when the patients stayed at
home (Kuskowska-Wolk 1990).  Furthermore an increased number of
measurement days and use of scales was supposed to improve reliability.
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 2.6 Validation of the dietary intake
 
 The use of dietary assessment methods to evaluate compliance may be
problematic since all these methods have their limitations (Crumb-Johnson et
al 1993). The major disadvantages with retrospective methods are memory
lapses and inadequate knowledge of food portions (Barret-Connor 1991).
Prospective food records are assumed to influence the respondent's dietary
behaviour and underreporting seems to be normal especially among women
(Block 1982). Because of the known limitations, dietary assessment
instruments should always be validated (Howat 1994). An absolute validation
of dietary intake is difficult to perform since it requires knowledge about the
true intake. Instead most scientists measure the relative validity by use of
biochemical markers. Another way to validate dietary intake is by means of
external independent markers relating reported energy intake to estimates of
basal metabolic rate, physical activity level and body weight (Sandström
1993, Black et al 1995).
 
 The following three methods were used in the validation procedure. They are
described in paper V:
 - 24-hour urinary nitrogen
 - physical activity level
 - weight development
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 3. Results and summary of papers
 
 The papers are summarised as follows:
 
 Paper I Nutrient intake and food choice among patients on a low fat,
low lactose diet
 
 Non-compliance in a dietary intervention study may cause inaccurate results
and weaken the reliability of study outcomes. Dilution of effect by control
subjects who decide on their own to adopt the dietary behaviour of the
treatment group is one other problem. This paper describes dietary intake in
the two groups in order to evaluate compliance. The foods eaten in order to
achieve a reduction in dietary fat to 40g per day are presented and the nutrient
intake is compared with Norwegian dietary guidelines.
 
 Dietary intake pre-treatment was measured by a 48-hour recall method.
During radiotherapy a 4-day food record method was used. Data was
collected during two periods, three weeks after start of radiotherapy and
during the last week of radiotherapy. The quantities eaten were estimated by
the patient and described in household measures as the number of units
consumed (cups, glasses, spoons, number of slices, pieces, decilitres). This
was translated to weights. The volume content in the hospital cups, glasses,
spoons etc. were measured. Slices of bread, cheese and other spreads prepared
by the kitchen were weighed. In addition, to get an impression of the serving
sizes an extra portion of food was ordered from the kitchen to a non-existing
patient. This was control weighed by the dietician on a dietetic scale. To
translate household measures used by the outpatients, tables of food portion
sizes were used. The total intake of energy, energy yielding compounds,
dietary fibre, calcium, iron, retinol, ascorbic acid, vitamin D, thiamine,
riboflavin and niacin were calculated by means of the FIBER software
package that is based on Norwegian food composition tables.
 
 No significant differences were found in energy intake, contribution of
macronutrients to the energy intake and nutrient intake before radiotherapy.
During radiotherapy the intervention group received a significant lower part
of the energy from milk products, meats, fats and sugar than the control
group, and consumed more energy from vegetables and fruits, cereals and
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fish. The intervention group had a higher intake of dietary fibre than the
control group (11.3 (4.1) g versus 9.0 (3.3) g per day, p=0.000). The low fat,
low lactose diet had an overall higher nutrient density than the ordinary diet,
however, not with respect to the fat-soluble vitamins.
 
 The intervention group had a qualitative different diet than the control group
during radiotherapy. The low fat, low lactose diet was achieved through a
reduction of milk products, fats and meats. The control group seemed to have
reduced the intake of fats and milk but not enough to obtain a diet similar to
the intervention group. The low fat, low lactose diet was a better diet in the
sense of nutrient density.
 
 
 Paper II Evaluation of the validity of the method used to assess
compliance to a low fat, low lactose diet in a dietary intervention study
 
 Dietary assessment instruments should always be validated because they all
have their limitations. Prospective food records are assumed to influence the
respondent's dietary behaviour and underreporting seems to be normal
especially among women. This paper describes an attempt to measure relative
validity by use of biochemical markers and to relate reported energy intake to
estimates of basal metabolic rate, physical activity level and body weight.
 
 During radiotherapy, the patients recorded their consumption of food, drink
and nutritional supplements during two 4-day periods. The first period (period
I) was three weeks after start of radiotherapy. The second (period II) was
during the last week of radiotherapy.  The food records were validated by
using 24-hour urinary nitrogen and the Goldberg cut-off 2 as standards. In
addition changes in body weight and energy intake (EI) were compared with
estimated energy expenditure (EER).
 
 For both periods there were no significant differences between the reported
protein intake and the intake estimated from the urine sample in any of the
groups. The EI in the intervention group was lower than in the control group
(p<0.01).  The EI: BMRest ratio were below the cut-off limit of 1.22 in the
intervention group at period I. At period II the ratio was below the cut-off
limit in both groups.
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 A mean weight reduction was observed in both groups during radiotherapy.
The observed weight reduction at period I corresponded to a mean energy
contribution from weight loss (EW) of 2.1 MJ per day in the intervention
group and 1.4 MJ per day in the control group. Mean total energy used
(TEU), (EW+EI), was respectively 8.1 and 8.4 MJ. TEU was significant
higher than estimated energy expenditure (EER) in both groups when using a
PAL of 1.27 to estimate the EER. EER was however not different from TEU
in any of the groups when a PAL of 1.55 was used to calculate the EER
(respectively 8.7 (0.8) MJ and 8.5 (0.7) MJ).
 
 The observed weight reduction at period II corresponded to a mean EW of
respectively 1.6 MJ and 1.0 MJ per day.  TEU at period II was respectiveley
7.3 MJ and 7.5 MJ.  No significant differences between TEU and EER were
found when using a PAL of 1.27. When using a PAL of 1.55 to calculate EER
(respectively 8.6 (0.8) MJ and 8.5 (0.7) MJ) it was higher than TEU in both
groups (p<0.01).
 
 The method used to measure dietary intake seemed to give a valid estimate of
the intake in the intervention period on which it was possible to make
conclusions about compliance. Even though the EI: BMRest ratios were below
1.22, a bias towards underreporting of EI it was not indicated. The reported
protein intake corresponded well to the protein intake estimated from 24-hour
urinary nitrogen excretion. There was also consistency between energy intake,
loss of body weight and estimated energy requirement.
 
 
 Paper III The influence of low fat, low lactose diet on diarrhoea during
pelvic radiotherapy
 
 This paper describes the ability of a low fat, low lactose diet to prevent
gastrointestinal side effects during the course radiotherapy. One hundred and
eighty three women with a primary diagnosis of gynaecological malignancy
(carcinoma of the endometrium, ovary and cervix, stage I and II) were eligible
for the study. Forty denied randomisation and 143 were included.  After written
consent, the women were randomised to receive either a low-fat, low-lactose
diet or the regular hospital diet.
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 During the entire period with radiotherapy they recorded use of anti-
diarrhoeal medication and daily number and consistency of bowel
movements. These registrations were converted to a diarrhoea scale where a
score = 2 indicated diarrhoea. Other treatment related symptoms like emesis,
nausea and loss of appetite were evaluated with the EORTC Core Quality of
Life Questionnaire C-36 version (EORTC QLQ-C36). The dietary intake was
measured prior to radiotherapy (48- hour recall), during the third and sixth
treatment week (4-days food record by household measures) and twelve
weeks after the start of the treatment (7-days weighed food record).
 
 Before the start of treatment there were no differences in bowel movements or
use of anti-diarrhoeal medication between the two groups. During the last
week of radiotherapy 14 patients (23%) in the intervention group reported
diarrhoea compared with 32 (48%) patients in the control group (p< 0.01).
The intervention group also used less anti-diarrhoeal medication than the
control group, 0.6 tablets per day versus 1.1 (p<0.01). Twelve weeks after the
beginning of radiotherapy, no group differences were found with regard to
bowel movements or medication. Emesis and nausea were no serious
problems in any of the groups. The highest incidence of nausea was found in
week 6. Five patients (8%) in the intervention group and six (9%) in the
control group (ns) experienced moderate to severe nausea. Twelve women in
each group (18% of the intervention group and 20% of the control group (ns))
reported substantial loss of appetite during the last week of radiotherapy.
During radiotherapy the intervention group had a lower energy intake than the
control group, 5.7 MJ versus 6.5 MJ (p<0.05). The mean daily fat intake was
respectively 34.3 g and 60.1 g (p<0.001). Weight loss was more pronounced
in the intervention group (mean reduction of 2.6 kg versus 1.7 kg) than in the
control group (p=0.06) during treatment.
 
 The incidence rate of acute diarrhoea the control was twice as high as in the
control group as in the intervention group, which indicated an effect of the
intervention diet. The lower incidence of diarrhoea did not result in reduced
weight loss.
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 Paper IV The effect of a low fat, low lactose diet on nutritional status
during pelvic radiotherapy
 
 Nutritional status of cancer patients can be negatively affected by cancer
treatment. With a low intake of fat it may also be difficult to maintain a
sufficient intake of energy. Results from the previous paper showed that more
patients in the intervention group lost weight than in the control group. This
paper describes the effects of the diet on the women' nutritional status during
and after radiotherapy.
 
 The following variables were used to evaluate nutritional status, weight loss,
arm muscle circumference (AMC), serum albumin (s-Alb) and serum
transferrin (TSF). More than 5% weight loss over one month and AMC, and
TSF below 90% of the lowest reference value were considered to be
pathological. Categories were assigned on the basis of two or more variables
having scores within that category. The following categories were used to
describe the nutritional status
 1) mildly depleted, 80-90% of the reference value
 2) moderately depleted, 60-80% of the reference value and
 3) severely depleted, less than 60% of the reference value.
 Where there was an equal choice between two categories, the most
pathological one was given preference.
 
 The mean weight loss during radiotherapy was 2.5 kg in the intervention
group and 1.7 kg in the control group (ns).  Six weeks after termination of
radiotherapy the intervention group had gained 0.6 kg, while the control
group had gained 1.1 kg (ns). Both groups had regained their initial weight
one year after start of radiotherapy.  Mean values of AMC, s-Alb and STF
were within the reference range in both groups during the entire observation
period. Only minor changes were observed within the groups during
treatment. During the last week of radiotherapy six patients (9%) in the
intervention group and 4 (6%) in the control group were mildly depleted (ns).
At 12 weeks and after one year none of the patients could be categorised as
malnourished.
 
 The patients in the intervention group did not seem to manage to compensate
for the lost energy intake due to fat reduction and the low energy intake lead
to weight loss during treatment. Despite this only minor changes in nutritional
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status were seen. After completion of radiotherapy the intake of fat increased
and both groups gained weight.
 
 
 Paper V Quality of life during pelvic radiotherapy
 
 This paper describes the effect of the diet treatment on the women's HRQOL. It
was expected that absence of diarrhoea could affect the women's HRQOL in a
positive way. At the same time it was possible that the low fat, low lactose
diet would be hard to accomplish and therefore not feasible. In such a case the
diet would be unacceptable for the women and possibly affect the HRQOL in
a negative way.
 
 HRQOL was defined as a multidimensional concept consisting of physical,
psychological and social variables and it was measured by using the EORTC
Core Quality of life Questionnaire 36-item version (EORTC QLQ-C36). The
questionnaire consisted of five functioning scales: physical functioning (7
items), role functioning (2 items), emotional functioning (8 items), social
functioning (2 items) and global health status/quality of life (2 items), and two
symptom scales: fatigue and malaise (5 items) and nausea and vomiting (2
items). Single items concerning appetite, diarrhoea, constipation, pain, dyspnea,
sleeping disturbances, alertness behaviour and financial impact were also
included.  A 10-item diagnosis specific module focusing on disease and
treatment related symptoms designed for the present study were used. The
measurements were done before starting therapy, during the last week of
treatment, six weeks after ending radiotherapy and every eighth week during one
year's follow up.
 
 The mean scores on the five functioning scales (physical functioning, role
functioning, emotional functioning, social functioning and global health/quality
of life) and the single item on financial impact during treatment, exposed no
statistically significant differences between the two groups. At 38th, 46th and
54th week the intervention group had a statistically significant lower score on
the role functioning scale than the control group (p<0.05), indicating a better
role function in the intervention group. The responses to the two symptom scales
(fatigue and malaise and nausea and vomiting) and the single items concerning
appetite, diarrhoea, constipation, pain, dyspnea, sleeping disturbances and
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alertness behaviour did also not expose any major differences between the two
groups. During the last week of radiotherapy diarrhoea was associated with
higher scores on the role functioning scale, physical functioning scale and the
fatigue and malaise scale within the control group. This was not found in the
intervention group.
 
 The intervention did not interfere with the patients emotional and social well-
being but it may influence the patients ability to cope with diarrhoea, as it
provides the patients with more control over their own situation.
 
 Paper VI Health related quality of life and occurrence of intestinal side
effects after pelvic radiotherapy
 
 The present paper assess the occurrence of late intestinal side effects in the
two groups 3-4 years after treatment and evaluates if the diet intervention
during radiotherapy had an impact on the occurrence of late effects. HRQOL
was evaluated and compared this with data from a random sample of women
of similar age, from the Norwegian population.
 
 According to the Population Register of Norway and the hospital files, 94 of
the women who completed the clinical trial, were alive and without known
relapse on November 1, 1993. They were approached by mail and asked to
complete a questionnaire package similar to the one they completed during
the clinical trial. Seventy-nine women (84%) returned the questionnaires after
one reminder. Use of anti-diarrhoeal medication, number and consistency of
bowel movements and present weight was recorded. Information about
significant late radiation injury (bowel complications requiring hospitalisation
and/or surgery) was collected from the hospital files. The women also
completed EORTC QLQ-C36. The scores on the EORTC QLQ-C36 were
compared with reference data from a random sample of 949 Norwegian
women aged 19-80 years. To be able to do so the scales and single items were
transformed linearly to a 0 to 100 scale. High score for a functional scale
represented a high/healthy level of functioning. High score for a symptom
scale/item represented a high level of symptoms/problems.
 
 No statistically significant differences between the two groups were found
regarding significant late radiation injury, diarrhoea and use of antidiarrhoeal
medication. The mean scores on the item measuring diarrhoea in QLQ-C36
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differed between the two groups, 19.4 (SD=25.4) in the intervention group
and 29.6 (SD=27.3) in the control group, though not statistically significant
(p=0.09). Three women (7%) in the intervention group and eight (22%) in the
control group scored 3 or 4 on the item concerning diarrhoea (p=0.05). In the
intervention group there was no statistically significant connections between
acute and late side effects. In the control group, however, a high score on the
diarrhoea scale during radiotherapy was associated with a high score 3-4
years after radiotherapy (p<0.05). Both groups had more diarrhoea than in the
general population, 23.8 versus 9.5 (p<0.01). Substantial diarrhoea was
associated deteriorated SF and fatigue. The HRQOL on the group level was
not much different than the population-based norms.
 
 As a group, the women with carcinoma of the endometrium and cervix
suffered from few treatment and/or disease related side effects 3-4 years after
radiotherapy. However, increased frequency of bowel movement was
common. Presence of substantial diarrhoea affected HRQOL negatively and
might interfere with nutrient absorption. Since our data indicated that the
women who had followed a low fat diet during radiotherapy had less
diarrhoea, nutritional guidance may be of importance.
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 4. General discussion
 
 Cancer therapies and their side effects may contribute to nutritional problems
and malnutrition. Patients with carcinoma of the endometrium or cervix that
receive pelvic radiotherapy may experience diarrhoea and weight loss. This
prospective clinical controlled study was conducted to evaluate if a low fat,
low lactose diet could be an appropriate treatment to relieve some of the
negative side effects of radiotherapy.
 
 4.1 The clinical study
 The effects on acute diarrhoea - comparison with other interventions
 The main hypotheses in this study was that patients, who kept to a low fat,
low lactose diet during pelvic radiotherapy, would experience less diarrhoea
than patients not making these restrictions. Our results confirmed this
hypothesis. During the last week of radiotherapy only 14 patients (23%) in the
intervention group reported diarrhoea compared with 32 (48%) patients in the
control group (p< 0.01). Dietary treatment did not eliminate diarrhoea totally.
This was however not expected since other factors than bile acid
malabsorption also are involved in the pathophysiology of radiation enteritis.
In a study of the intestinal function during radiotherapy only four of 11
patients had impaired bile acid absorption (Yeoh, Lui and Lee 1984). Other
factors that might be involved in the pathogenesis are reduction in the activity
of aminopeptidases, imbalances in local bacterial flora, changes in intestinal
motility and exo- and endogenous toxins (Henriksson et al 1999).  Treatments
focusing on these factors have been evaluated in clinical trials but the results
do not indicate that such treatments are more effective than a low fat, low
lactose diet in preventing radiation induced diarrhoea.
 
 Elemental diets (pre-digested feeding formula) may protect against radiation
enteritis because they reduce pancreatico-bilary secretion (Bounous et al
1980). In clinical trials these diets have reduced diarrhoea and even reduced
the severity of late effects (Bounous et al 1975, Craighead and Young 1998).
One problem with elemental diets that makes difficult to recommend such
treatment, is the lack of palatability and poor compliance (Bounous 1980). A
more recent study did however conclude that elemental diets are well
tolerated (Craighead and Young 1998).  This conclusion was based on
experience from a study on 17 patients. Twenty three percent of these patients
URN:NBN:no-2118
58
did not comply with the elemental diet. Compared to our results where about
10 % withdrew because of the diet, 23% is a considerable portion of non-
compliance. Elemental diets are very different from normal food, which
possibly is their main disadvantage. Even if they help against diarrhoea, a
craving for normal foods and meals may lead the patients to give up on such a
diet treatment.
 
 Sucralfate, an aluminium hydroxide complex of sulfated sucrose which
protect exposed mucosa, have been evaluated in a double blind and placebo-
controlled study with 70 patients with carcinoma in the prostate or urinary
bladder (Henriksson, Franzen and Littbrand 1992). The results showed a
reduction in frequency of bowel movements and less pronounced weight loss
in the sucralfate group. One year later, the patients in the sucralfate group
displayed significantly fewer problems with diarrhoea than the placebo group.
These results were not reproduced in a later study were sucralfate was given
once daily during radiotherapy and for two weeks following radiotherapy
(OBrien et al 1997).  No significant differences were found between the
placebo and sucralfate. Respectively 95% and 88% suffered from side effects
during radiotherapy.  They conclude that sucralfate can not be recommended
as routine treatment.
 
 Eicosanoids (prostaglandins, thromboxanes and leukotrienes) and free
radicals release may be involved in the pathogenesis of radiation enteritis. The
eicosanoids produce a wide range of biological effects and inflammatory
responses. Mesalazine is a potent inhibitor of their synthesis and as such it has
been evaluated in a randomised double blind study (Resbeut et al 1997).  One
hundred and fifty patients receiving external radiotherapy to the pelvis were
included. All patients followed a low fibre and low lactose diet. The results
showed that severity and duration of diarrhoea, use of antidiarrhoeal agents
and body weight did not differ between groups.  They concluded that
Mesalazine 4 g/day did not decrease the symptoms of radiation enteritis.
 
The justification for using a low fat, low lactose diet was bile acid
malabsorption. One could argue that instead of using a diet it would be
possible to use bile acid sequestering resins like cholestyramine.
Cholestyramine is however considered being unpalatable and it may be
difficult to maintain a comfortable balance between diarrhoea and
constipation. In the literature it is also indicated that cholestyramine should be
used with caution, since an increase in pre-existing fat malabsorption may be
induced and thereby worsen the diarrhoea (Danielsson et al 1991).  Taking
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this into consideration a low fat diet based on modification of normal foods
would be preferable. Cholestyramine could be offered to patients not
obtaining a control of the diarrhoea with the diet.
 
 The effects on the appearance of late injuries
 Both the uses of elemental diets and sucralfate during radiotherapy have been
suggested to influence the appearance of later bowel effects (Craighead and
Young 1998, Henriksson, Franzen and Littbrand 1992). We were also able to
show a small influence of the diet on late effects. Diarrhoea seemed to be less
frequent if the women had eaten a low fat diet during radiotherapy but the
difference was not statistical significant. Such a statistically significant
difference would however be difficult to detect since only a few of the women
reported significant diarrhoea during follow up.  Nevertheless, diarrhoea was
more prevalent among the former cancer patients than in the general
population. Among those women experiencing significant diarrhoea social
wellbeing and fatigue were negatively affected. This finding was not
surprising. During clinical practice we have met patients with late radiation
diarrhoea who have described how diarrhoea influence their social life. They
are afraid to go out because they have no control over their bowel movements
and need to have a toilet available constantly. To learn and get familiar with
low fat, low lactose diet during radiotherapy could therefore be beneficial.
The literature clearly indicate that bile acid absorption may be present in
patients with late effects (Yeoh et al.1993A, Danielsson et al 1991) and
metabolic studies have shown that low fat diets may correct bile salt
malabsorption (Andersson, Isaksson and Sjögren 1974).
 
 Diarrhoea and HRQOL
 It is assumed that maintenance of body composition and adequate nutritional
status can help patients with cancer to maintain or improve functional status
and to feel and look better. Because of this we expected that presence of
diarrhoea would affect HRQOL negatively. Despite more diarrhoea in the
control group during radiotherapy we did not detect any differences in general
well being between the two groups. Cancer patients may tolerate a high level
of symptoms during treatment and report good satisfaction with life anyway
(Kaasa et al 1991). Satisfaction with life is a general measure that possibly
does not capture moderate health-related problems. Since diarrhoea during
radiotherapy might be regarded as a minor problem by the patients it will not
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affect measurements of general well being significantly. Within the control
group, however, we found an indication of a negative influence of diarrhoea.
Patients having diarrhoea experienced more fatigue and limitations in role
functioning and physical functioning than the patients not having diarrhoea. In
the intervention we found no such negative influence. This is an interesting
finding, which we have explained by that diet intervention during
radiotherapy might influence the patients' ability to cope with diarrhoea by
giving them more control over their own situation (Ganz 1988).
 
 Three to four years after radiotherapy a low frequency of treatment and/or
disease related side effects were detected.  Not surprisingly all measures of
general well being were good. But also here we found that high levels of
symptomology were associated with fatigue and deteriorated functioning.
 
 The Diet
 The term diet is derived from the Greek word diata and may be translated as
life pattern (Schlettwein-Gsell 1992).  Diet has a meaning of ration,
compulsion and control in every culture. These negative aspects of a diet may
be very strong in connection with cancer because one would like the patients
with cancer to enjoy their meals and eat what they like in a period that
everything else seems difficult. A low fat diet, which was used in the present
study, is a diet in every meaning of ration, compulsion and control. The
withdrawal in the intervention group during the first six weeks (9.8%) may
reflect that it was not easy to comply to the diet and that the restrictions given
were rigid. After the first weeks the number of withdrawals decreased. This
may indicate that when they learned about the diet and experienced how it
worked it was easier to cope with it. On the other hand it may reflect that the
intervention group ignored the diet when they left the hospital. However, our
data on dietary intake does not support this assumption.
 
 We did not find any differences in nutritional status between the two groups
during radiotherapy. These findings indicate that our hypothesis that less
diarrhoea during radiotherapy will contribute to maintenance of good
nutritional status during treatment must be rejected. The main problem for the
patients in both groups was to maintain energy intake during treatment. The
fat reduction was mainly obtained by eating less high-fat milk-products,
visual fat and meats. The problem was to increase in the intake of fruits,
cereals and vegetables sufficiently. This is in accordance with findings from
other studies where they have evaluated the feasibility of low fat diets (Ikkala
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et al 1991, Insull et al 1990, Sheppard, Kristal and Kushi 1991, Kendall et al
1991, Prewitt et al 1991). Even young healthy men may have problems to eat
enough if the fat intake is low (Sandström, Marckmann and Bindslev 1992).
 
 In our study reduced appetite was documented in both groups, a common
problems for almost all patients with cancer (Bruera and MacDonald 1988,
Ottery 1995). For some of the patients it may be impossible to eat enough
food to meet the metabolic needs. Medium Chain Triglycerides (MCT-fat)
and/or other nutritional supplements may therefore be necessary in the diet for
patients with high energy needs (Hessov and Ovesen 1995).  But even if
effeort is made to motivate the patients to maintain energy intake this might
be difficult especially if they are women. We experienced that many of the
women were very pleased to loose weight. Some of them expressed that for
the first time in their life they were able to loose weight without struggle.
With such opinions it might be difficult to make overweight cancer patients
not loosing weight. This assumption is supported by that primarily overweight
women lost weight during radiotherapy in our study. All these factors show
that close follow-up and proper diet counselling are crucial to succeed when
dealing with a low fat diet to cancer patients.
 
 Counselling on the diet
 A person who is going to change the diet needs information and education in
how to achieve the necessary changes (Crumb-Johnson et al 1993). Strict
rules and prohibition to eat certain foods may cause a diet with no variety,
lack of nutrients and weight loss (Polivy 1996). People who are given advise
that is difficult to keep may be irritable and very concerned about food and
how to eat. Restrictions may also lead to periods of excessive eating or even
compulsive overeating (bingeing). It is shown that the way the dietary
counselling is performed and the relationship between counsellor and patient
are of importance for compliance (Crumb-Johnson et al 1993). A study done
to evaluate barriers to the adoption of low fat diets showed that reduction in
taste quality of the diet seem to be the major problem (Lloyd, Paisley and
Mela 1995). Dietary changes should be done gradually giving the patients a
possibility to become accustomed to the different taste of the new diet. This
type of strategy is however not possible when you change to a low fat diet
during a limited treatment period.
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 A Swedish study showed that it is possible to reduce the intake of fat by
individual dietary counselling by a dietician (Ikkala et al 1991). At the
beginning they met often and they had contact over telephone during the
follow up period. The dietician taught the women in nutrition skills such as
low fat cooking methods, supplementing their meals with carbohydrate foods
and best food choices while shopping.  In a study where the dietary
counselling aimed at reducing dietary fat intake from about 39 % of energy to
20 % it was concluded that the fat reduction was made possible through
education and dietary counselling (Insull et al 1990).  In the counselling it was
emphasised to make plans for how to eat instead of giving the patients a
prescribed diet. The plans were individualised and possible to change
according to the patients' dietary habits.
 
 For the patients it may be difficult to recognise what comprises effective
dietary changes when reducing the fat (Lloyd, Paisley and Mela 1995).
Subjects may believe that they have lowered their fat intake and consume the
recommended amount of fat. Dietary records however indicate that they still
consume a diet containing a high percentage of the energy from fat.  If a
patient is going to succeed in reducing the fat intake as well as the lactose
intake, it is important to give feedback on progress. Counselling on fat content
of foods and the total amount of fat to eat each day are other factors that can
make it easier to obtain the goals (Lloyd, Paisley and Mela 1995). Low-fat
recipes may also be of importance and since it may be particularly hard to
comply with a low fat diet when they were dining out or with friends, this
should be discussed during counselling.
 
 All data indicate that a diet must be carefully planned in order to be
acceptable for the patients. The principles are better understood and
motivation is secured if practitioner and patient work closely together during
the planning process (Williams 1995A). An individual tailoring of the diet to
personal needs and desires seem also essential. The women in our study were
given individual advice on the type and quantity of foods to eat.  The dietary
counselling was based on information about usual dietary intake and the diet
was individually tailored. The dietician had contact with the women almost
every day and the dietary advises were repeated when necessary.  The efforts
made to educate the patients in the diet resulted in a high degree of
compliance, which was documented, by the results from the food records.
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 4.2 Methodological issues
 Internal validity
 The advantage of clinical trials is that their experimental design can provide
direct evidence of a cause-and-effect relationship (Langseth 1996, Bowling
1997). In the present randomised clinical trial we were able to show a cause-
effect relationship between the low fat, low lactose diet and the occurrence of
diarrhoea during pelvic radiotherapy. For this conclusion to be internally
valid, the experiment must be designed so that conditions other than the diet
are ruled out as potential causes for the reduced diarrhoea in the intervention
group (Bowling 1997).
 
 Selection - mortality
 The randomised design of our study secured that variables not observed
should be distributed by chance between the groups and thereby minimising
the possibilities for bias (Willett 1990). Despite the randomised design it
could be a source of bias and a threat to the external validity if the people
managing the study selected patients into the study. We have no reason to
believe that it was the case in our study. Only two persons were responsible
for enrolment and the inclusion and exclusion criteria were followed. The
study population was recruited from the gynaecological department at NRH.
All that patients that fulfilled the inclusion criteria during the period may
1988 trough may 1990 (183 women) were eligible and invited to participate.
Seventy-eight percent were consecutively included. The included patients
should therefor be representative for the gynaecological patients undergoing
pelvic radiotherapy at NRH during this period.
 
 In the course of an experiment, some subjects may drop out before it is
completed. In such a case different scores between the two groups on the
dependent measure, may be due to an unique characteristic of subjects able to
endure a particular condition, a subject-related variable that would be
disproportionately present in each group (Bowling 1997). The withdrawal in
the intervention group was higher than in the control group during the six first
weeks of the clinical trial. Seven withdraw in the intervention group and four
in the control group, a difference that was not big enough to result in unequal
distribution of subject-related variables.
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 After the first 12 weeks the withdrawals were mainly because of recurrence or
death. This implies that the evaluation of HRQOL that is made mainly reflects
the condition of the cured patients but this applies to both groups and should
therefore not influence the results.
 
 Diffusion or imitation of treatment
 This occurs when a control group learns about the intervention program and
decides to adopt the dietary behaviour of the treatment group (Willett 1990).
This threat to validity tends to equalise the outcomes between groups,
minimising the chance of seeing a program effect even if there is one. Non-
compliance in the intervention group may also result in such an inaccuracy.
 
 To inhibit diffusion or imitation of treatment intervention trials should
optimally be conducted as double-blind experiments. If subjects are randomly
assigned to intervention or control groups and the subjects do not know what
treatment they get, one can assume that any difference that develops between
the groups is directly caused by the factor under investigation (Langseth
1996, Bowling 1997). Unfortunately it is impossible to administer
intervention trials based on counselling as double-blind experiments
(Langseth 1996). Such a design would create a very artificial situation and
limit the degree to which one could generalise the results to a real contexts
(reduced the external validity). One could imagine that one could overcome
the problem by recruiting the patients from separate hospital wards and
randomise the wards each of the treatments. This would however imply
problems since the trial no longer would be a true experiment (Bowling
1997).  It would be difficult to ensure the comparability of the units.
 
 If blinding is impossible one must rely on the subjects self reported diet
compliance (Crumb-Johnson et al 1993).  In this study dietary intake was
measured to detect possible non-compliance in the intervention group and
imitation in the control group. Our data did not indicate that the control group
had managed to eat a low fat, low lactose diet. The fat intake in the control
group were however low and lower than in the general population. It was not
possible to conclude that this was a result of imitation. It could also simply be
an effect of the low energy intake. The results from the validation study of the
dietary assessment methods indicate that we can trust the dietary data. Energy
intake was low but it agreed with the observed weight reduction.  In addition
the protein intakes measured by 4-day food records were in accordance with
the intakes estimated from the urine samples.
URN:NBN:no-2118
65
 
 After the 12 first weeks of the study the diet intervention ended. The women
were allowed to eat, as they wanted. Data on dietary intake showed that the
fat intake increased in both groups but it was still lower than in the general
population. This might have influenced our results and minimised the chance
of showing an effect on late side effects.
 
 Measurements
 Time for measuring
 It is important to plan the timing for measurements in order to detect expected
changes at appropriate time periods (Bowling 1997). We performed
measurements at the 3rd and last week of radiotherapy since diarrhoea was
expected to occur at these times (Yeoh and Horowitz 1987). A new
measurement was performed 6 weeks after end of radiotherapy when
diarrhoea was expected to cease. The patients made records over their bowel
movements during the entire treatment period and the six weeks following
radiotherapy. The results showed that the frequency of bowel movements
increased gradually and reached a peak during the last week of treatment.
After treatment a similar decrease was seen. This indicates that timing for
performing measurements were appropriate to detect any effects of the dietary
intervention.
 
 We planned the follow up period to be one year to detect any long term
effects of the use of a low fat, low lactose diet during pelvic radiotherapy. Our
hypothesis was that the diet could reduce the risk of developing late radiation
injury and chronic diarrhoea. In the literature it was indicated that late
radiation complications usually appear six to 24 months after treatment
(Berthrong and Fajardo 1981, Kinsella and Bloomer 1980). We did not find
any signs of late complications after one year and since such complications
may occur at any time during the lifetime of the patient (Coia, Myerson and
Tepper 1995), we decided to make a new evaluation 3-4 years after
radiotherapy. Also at this point we found few indications of late
complications. A longer follow-up might have detected more complications
but it would have been too expensive to conduct such a study.
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 Instruments
 A diary card was used to measure diarrhoea. This implied that we had to rely
on the patients' own registrations. This could theoretically have lead to two
kinds of threats to the internal validity of the study. The patients in the control
group might have felt "jealous" about the dietary program in the intervention
group. This could have leaded them to decide to show how well they could do
without the diet. This threat generally works to in the direction of equalising
the results and makes it more difficult to detect an effect if there is one. The
other threat could be that the intervention group wanted to please the people
responsible for the study and therefore record less bowel movements than
they actually had (Bowling 1997). This threat would go in the other direction
making the diet intervention look even more effective than it actually was.
We have no reason to believe that any of these threats were more prominent
and if they existed they would have balanced each other.
 
 One reason for assuming that the patients did not try to please the people
responsible for the study was the finding of low correlation between the data
from the diary card and the diarrhoea item in the HRQOL questionnaire in
both groups. The records showed a higher frequency of bowel movements
than the HRQOL item did which indicate that they were accurate in their
registrations. This finding also made us conclude that the when measuring
specific phenomena such as diarrhoea in a clinical trial, the EORTC
questionnaire does not seem to be sensitive enough. Specific trial-related
instruments are therefore recommended to use.
 
 More objective measures of diarrhoea would exclude the threats to the
internal validity of the study because of the patients' own registrations. This
was not possible because of limited assets and human resources. Absorption
of 75SeHCAT (a synthetic bile acid analogue) and serum levels of vitamin
B12 could have been such objective measures (Ludgate and Merrick 1985,
Snijders-Keilholz et al 1993, Yeoh et al 1993A).
 
 External validity and clinical implications
 External validity is related to generalising and is the degree to which the
conclusions in the study would hold for other persons in other places and at
other times (Bowling 1997). We have already concluded that the included
patients was representative for the gynaecological patients undergoing pelvic
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radiotherapy at NRH during the actual period. Strictly we can not generalise
the results from this study to other groups of patients. However, we believe
that patients receiving pelvic radiotherapy as their only treatment may be
recommended a low fat, low lactose diet in order to prevent diarrhoea. Bile
acid malabsorption has also demonstrated both in patients treated for
seminoma of the testis (Yeoh et al 1995) and patients treated for rectal
carcinoma experience the same problems with diarrhoea (Letschert et al
1994).
 
 Since measurements of the absorptive function of the small intestine during
pelvic radiotherapy have indicated that low lactose diet is a minor problem
one may question if it is necessary to reduce both fat and lactose. Our design
makes it difficult to decide what was the main effect, low lactose or low fat.
This implies that our guidelines strictly must include both diet modifications.
Despite this it is a possibility that low fat is the most important factor.  One
can also argue that it might be possible to intervene for a shorter period of
time since diarrhoea seems to develop gradually (Berthrong and Fajardo
1981). In this way it would also be possible to make dietary changes gradually
so it would be easier to comply. Strictly we can not say that such a strategy
would give the same effect on diarrhoea as the diet applied in our study. In all
studies evaluating the effect of dietary changes during radiotherapy the diet
have been introduced from the start of treatment. Especially in question of
preventing radiation injury it is possible that the diet should be used the entire
treatment period.
 
 Cancer patients are often concerned about what to eat and they may want to
intervene themselves and thereby stay in control over their own life (Schmale
1979, Tchekmedyian, Cella and Heber 1999). The diet is one of the few areas
where the cancer patient has some kind of control. Studies have shown that
patients who experience diarrhoea tend to change their diet (Hulshof 1987).
An American study showed a wide variety of foods which women with
chronic radiation enteritis reported to worsen the symptoms from the intestine
(Sekhon 2000). Bran muffins, popcorn, broccoli, salad, peas, beans and fried
fish are just some examples. Generally it is difficult for individuals to locate
the food items that are causing the symptom on a mixed diet. This may lead to
exclution of necessary foods and thereby generate a diet that is monotonous
and low in nutritional value. Some may also become afraid to eat and loose
weight. In such cases a low fat, low lactose diet would be an alternative. The
diet has a documented effect and if the food plans are followed the diet is
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fully nutritional acceptable. The low fat, low lactose diet even seemed to be a
better diet in the sense of nutrient density than the normal hospital diet.
 
 Furthermore, if cancer patients are given proper dietary counselling it might
prevent them from seeking unproven diet therapies. Risberg et al (1995)
found that diet was one of the most prevalent forms of non-proven therapies
used among Norwegian cancer patients. One other study has showed that 12%
of patients undergoing radiation therapy for prostate carcinoma used special
diets as complementary treatment (Kao and Devine 2000). The patients seem
to believe that such therapies might improve physical resistance and/or their
general condition (Risberg et al 1997). When it comes to non-proven diet
therapies they unfortunately often have the opposite effect of improving
physical resistance, since they are high in volume and unbalanced they may
lead to weight loss and malnutrition.
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 5. Conclusions
 
 The results from this thesis can be summarised as follows:
 
 The patients receiving a low fat, low lactose diet (intervention group) had
a higher intake of water-soluble vitamins than the patients receiving a
regular hospital diet (control group). The intake of fat-soluble vitamins did
not differ between the two groups.
 
 During radiotherapy and six weeks after end of therapy the intervention
group had a lower intake of fat than the control group. The dietary
counselling lead to high compliance in the intervention group and the diet
was well accepted.
 
 The intervention group had less diarrhoea and used less Loperamide
during radiotherapy than the control group.
 
 No differences in nutritional status were found between the two groups.
The low fat diet lead to reduced energy intake because of incomplete
compensation of energy loss due to fat reduction. The energy intake in the
control group was also low and weight loss was found in both groups.
 
 In the control group diarrhoea increased fatigue and had negative effects
on physical functioning and role functioning during radiotherapy. We did
not find that diarrhoea influenced HRQOL in the intervention group.
 No differences in late radiation injury and chronic diarrhoea were found
between the two groups one-year and 3-4 years after treatment. Compared
with the general Norwegian population, frequent bowel movements and
diarrhoea were more prevalent in both groups 3-4 years after radiotherapy,
but most prominent in the control group. Diarrhoea as a late effect seemed
to increase fatigue and have a negative influence on social well being.
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 Errata
Paper I
Page 276. Table 5. The number 2 for patients declining the study during the 6th week in the
control group should be replaced by 1.
Page 279. Results.  First sentence. The correct sentence should be: A total of 11 women
(7.7%) withdrew from the study during the course of radiotherapy, seven (10%) in the
intervention group and four (5.6%) in the control group.
Paper III
Page 148. Second section, line 2 and 3 from the top. The correct mean age should be 57.1
in the intervention group and 55.5 in the control group.
Page 149. Second section, under results, first paragraph, last sentence. The correct
sentence should be: Four patients who left the study did so during the first week, six during
the 3rd week and one during the 6th week.
Paper IV
Page 91. First section,  under results, second sentence. The correct sentence should be: A
total of  114 patients (80%) completed the study (55 in the intervention group and 59 in the
control group).
Page 91. Table 2. The correct mean age should be 57.1 in the intervention group and 55.5
in the control group.
Page 91. Second section,  line 9-12 from top. The correct mean age should be 57.1 in the
intervention group and 55.5 in the control group. The correct mean weight should be 70.6
in the intervention group and 67.0 in the control group.
Paper V
Page 149. First section,  under results, 5th line. The correct sentence should be: A total of
114 patients (80%) completed the study (55 in the intervention group and 59 in the control
group).
Page 149. First section,  under results,  line 7-10. The correct mean age should be 57.1 in
the intervention group and 55.5 in the control group. The correct mean weight should be
70.6 in the intervention group and 67.0 in the control group.
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2Abstract
Background and Aims: An open prospective randomised study was
conducted to evaluate the effect of low fat, low lactose diet on diarrhoea
during radiotherapy.  The aim of the present study was to evaluate the
validity of the dietary intake, measured to assess compliance to the diet.
Methods: 143 women with gynaecological malignancies undergoing pelvic
radiotherapy were included in the clinical study. Dietary intake during
radiotherapy was measured by a 4-day food record method. The method
was validated by 24-hour urinary collections, study specific cut-off limit
for ratio between energy intake (EI) and basal metabolic rate (BMR) and
comparison between EI and weight loss.
Results:  The protein intakes measured by 4-day food records were in
accordance with estimated protein intakes. The EI: BMR in the intervention
group was below the cut-off limit at period I. At period II the ratio was
below the cut-off limit in both groups. A mean weight reduction was
observed in both groups during radiotherapy, and the EI agreed with the
change in body weight.
Conclusion: The method used seemed to give a valid estimate of the dietary
intake on which it was possible to make conclusions about compliance to
the diets.
Key words: Dietary assessment, validity, diet intervention, genital
neoplasm, radiotherapy
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3Introduction
A randomised prospective clinical trial was carried out to evaluate the
effect of a low fat, low lactose diet on intestinal side effects during
radiotherapy.  The diet was used prophylactic and during the last week of
radiotherapy 23% in the intervention group reported diarrhoea versus 48%
in the control group (p< 0.01) (1).  Dietary intervention trials should
optimally be conducted as double-blind experiments to be able to conclude
that any difference that develops between the groups is directly caused by
the factor under investigation (2,3). Unfortunately it is not possible to
administer an intervention trial based on counselling as a double-blind
experiment (2).  This implies a risk of adoption of the intervention program
in the control group and non-compliance in the intervention group (4,5).
Both adoption of the intervention program and non-compliance tend to
equalise outcomes between the groups, minimising the chance of seeing an
effect even if there is one. Compliance with the diet in both groups was
evaluated by collecting dietary data. The mean daily fat intake was 34 g the
intervention group and 60 g the control group (p<0.001) which indicated
that the intervention group had made the necessary changes and that the
control group had not adopted the diet.
During radiotherapy a prospective food record for 4-days was used to
evaluate compliance (6). It is well known that all dietary assessment
methods have their limitations. One must rely on information given by the
subjects themselves and recording of food intake may alter the respondent's
dietary behaviour (5,7). Especially among women underreporting of energy
intake is a well-known problem (5). Because of the known limitations, one
should try to validate the measured dietary intake (8). One way to validate
is to use biochemical markers. The advantage of using a biochemical
marker is that measurement errors are essentially not correlated with errors
in any dietary method  (9). The excretion of nitrogen in a 24-hour urine
specimen, which is an estimate of dietary protein intake, is considered as
one of the best biochemical markers to validate dietary surveys (10,11). 
Another way to validate dietary intake by means of external independent
markers is to relate reported energy intake to estimates of basal metabolic
rate, physical activity level and body weight (12,13,14).
In this study an attempt was done to evaluate the validity of the collected
dietary data by using 24-hour urinary collections, study specific cut-off
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and comparison between EI and changes in body weight.
Materials and method
Subjects
Between May 1988 and May 1990, 183 women admitted to the Norwegian
Radium Hospital were eligible for inclusion in the clinical trial. One
hundred and forty-three (78%) women were included. The rest refused to
participate or were lost for inclusion. The selection criteria were primary
diagnosis of carcinoma of the endometrium, ovary or cervix; external
pelvic radiotherapy at a minimum dose of 44 Gy or 40 Gy if combined with
intracavitary treatment; age < 75 years and WHO performance status of = 2
(15). Patients with the diagnosis of inflammatory bowel disease or
ulcerative colitis were not included. Other criteria for exclusion were
planned surgery after completion of radiotherapy and previous treatment
with chemotherapy or radiotherapy. Patient characteristics are given in
Table 1. More detailed information about eligibility criteria, staging and
treatment regimens are presented elsewhere (1,16). Ethical approval for the
study was obtained from the Board of Ethics of Health Region II.
Experimental design
The patients signing the consent form, were randomised before
radiotherapy to receive either a low fat, low lactose diet (maximum of 40 g
fat per day and maximum 5 g lactose per meal) or the regular hospital diet,
during the treatment period and six weeks afterwards. The regular hospital
diet had average fat content of 80 g at 6.9 MJ (44% of energy from fat).
The content of lactose in the regular diet was not calculated, but the
planned menu contained three glasses of milk at a 150-ml each and 10g of
brown cheese daily (24.5g of lactose). Milk was also used in sauces,
desserts and porridges.
Seventy-one patients were assigned to the intervention diet and 72 to the
control group. The majority of the patients (101 patients) were hospitalised
during the six weeks of radiotherapy, but a few from each group (18
patients in the intervention group and 24 patients in the control group) were
receiving treatment as outpatients. The hospitalised patients received three
meals a day (breakfast, dinner and supper) from the hospital kitchen. The
outpatients prepared their own food. The low fat, low lactose diet was
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in detail elsewhere (1). The patients in the intervention group were given
individual advice on the type and quantity of foods to eat. The aim of this
counselling was to secure compliance if they ate something in addition to
the hospital meals or were outside the hospital. The dietary counselling was
also necessary for the outpatients who prepared their own food. Patients in
both groups were advised to eat enough to maintain weight during
radiotherapy and to use nutritional supplements if necessary.
Dietary intake: food record by household measures
During radiotherapy, the patients recorded their consumption of food, drink
and nutritional supplements for four consecutive days (18,19). They
received oral and written instructions in keeping an accurate record, and
were asked to complete the records in two 4-day periods. The first period
(period I) was three weeks after start of radiotherapy. The second (period
II) was during the last week of radiotherapy.  Household measures were
used to describe serving sizes. The patients received a diet controlled by the
hospital kitchen. As control of the serving sizes, an extra portion of food
was ordered from the kitchen and weighed by the dietician on a dietetic
scale. At the end of each four-day period, the dietician reviewed the records
to probe for items that might have been forgotten.
The 4-day food records were validated by using 24-hour urinary nitrogen
(10) and the Goldberg cut-off 2 (12) as standards. In addition changes in
body weight and energy intake (EI) were compared to estimate energy
expenditure (EER). The energy, fat, carbohydrate and protein intake, were
calculated by means of the FIBER software package based on Norwegian
food composition tables (20). This program package did not calculate the
content of lactose.
Urinary nitrogen
The patients were instructed to collect one 24-hour urine specimen during
each food record period.  Oral and written instructions in the collection
technique were given. The first morning urine passed on the collection day
was discarded and the time noted. All urine passed in the next 24-hour was
collected until the noted time next day. The dietician collected the urine and
it was then carefully mixed, weighed and frozen. Volume was calculated
from urine density and sample weight. The samples were stored at - 20º C
before they were analysed for nitrogen using a model 720/771 Antek
Chemiluminescent Analyser (21). No markers were given to verify the
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record any spillage during the 24-hour period. Protein intake was estimated
from the equation: 6,25 x (urine nitrogen (g) +2) (10).
Estimation of basal metabolic rate and total energy expenditure
The Harris Benedict's equation (22) was used to estimate BMRest. BMR
(female)=(655 + 9.6W + 1.7H) - 4.68A, where BMR is measured in
kilocalories, W= weight in kilograms, H= height in centimetres and A=age
in years. This equation is commonly used to estimate basal energy
expenditure in hospitalised patients. Height and weight were recorded
before the start of treatment. During radiotherapy the patients were
weighed every week on an electronic bathroom scale. The patients were
weighed on the same scale, in the morning after passing urine and faeces
and with the same clothing. Weight changes between baseline and period I,
and between period I and II were calculated.
Total daily energy expenditure (TEE) is the sum of BMR, thermic effect of
food eaten and the energy expended in physical activity.  The TEE may be
expressed by multiplying BMR with a factor matching the physical activity
level (PAL).  PAL can be defined as the average activity ratio for different
types of activities over a 24-hour period and varies with intensity of
physical activity. EER was obtained by multiplying BMRest with a PAL of
1.55 and 1.27 (23). Since it was assumed that most of the women had low
physical activity during hospital stay a PAL of 1.55 associated with a
sedentary life-style (light occupational work), was used. Previous results
from the present study showed that the patients experienced increased
fatigue and malaise during the last week of radiotherapy (24) and spent
most of the time in bed or in a chair.  Because of this a PAL of 1.27 that
allows for minimal movement, was also used.
A basic premise is that if weight is stable then the TEE equals EI.
Imbalance between TEE and EI will either result in weight loss or weight
gain. If a weight loss of 0.5 kg per week was registered, an energy
contribution from the weight change of 2.1 MJ per day was expected (25). 
The daily energy contribution from weight change (EW) was calculated by
multiplying weight change per week with 2.1 MJ/0.5 kg. Total energy used
(TEU) was calculated by adding EI and EW. Correspondence between TEU
and EER was set to indicate that the calculated EI was representative for
the actual intake during the observation period.
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impression of how much of the registered EI is available for physical
activity. To evaluate the validity of the reported  EI, the Goldberg cut-off 2
was calculated, using a PAL of  1.27, energy requirement for a totally
sedentary lifestyle, n=130 and 8 days of records (12,26). The cut-off was
calculated to 1.22. An EI: BMRest ratio below 1.22 was recognised as an
indication of underreporting of EI.
Statistical analysis. The SPSS for Windows V6.1 program was used for the
statistical analysis. Means and standard deviations are reported for the
nutrients estimated. Students' t-test was used to test for mean differences
between the groups. Differences within groups were tested with a pairwise
t-test. In case of missing values it were replaced with the group mean.
Results
Seven patients (9.8%) in the intervention group and 4 (5.5 %) in the control
group withdrew from the study during the course of radiotherapy. In the
intervention group six patients did not wish to go on with the low-fat, low-
lactose diet. The reasons were the taste and worry about not managing the
diet for six weeks at home.  One patient had alcohol problems and did not
follow the diet. One patient in the control group changed to a low-fat diet.
The other reasons for withdrawal were too much paper work or not known.
Forty-nine patients in both groups collected urine during period I. Sixty-
two patients in the intervention group and 68 in the control group
completed the food record. During period II respectively 48 and 52 patients
collected urine while 62 and 67 completed the food record.The reasons for
the low number of urine collections were incomplete urine samples and
problems with urine collection among some of the outpatients.
Statistical significant differences between the two groups with respect to fat
intake were found during the intervention period (table 2). There were also
significant differences between the two groups with respect to contribution
of macronutrients to the energy intake.
Validation of the 4-day food record against the 24-hour urinary nitrogen is
presented in table 3. For both periods there were no significant differences
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sample in any of the groups.
Validation against the Goldberg cut-off 2 and EI and weight change is
presented in table 4. The EI in the intervention group was lower than in the
control group (p<0.01).  The EI: BMRest ratio were below the cut-off limit
of 1.22 in the intervention group at period I. At period II the ratio was
below the cut-off limit in both groups. A mean weight reduction was
observed in both groups during radiotherapy, more pronounced in the
intervention group than in the control group but not statistically significant.
The observed weight reduction at period I corresponded to a mean energy
contribution from weight loss (EW) of 2.1 MJ per day in the intervention
group and 1.4 MJ per day in the control group. Mean total energy used
(TEU), (EW+EI), was respectively 8.1 and 8.4 MJ. TEU was significant
higher than estimated energy expenditure (EER)  in both groups when using
a PAL of 1.27 to estimate the EER. EER was however not different from
TEU in any of the groups when a PAL of 1.55 was used to calculate the
EER (respectively 8.7 (0.8) MJ and 8.5 (0.7) MJ).
The observed weight reduction at period II corresponded to a mean EW of
respectively 1.6 MJ and 1.0 MJ per day.  TEU at period II was respectiveley
7.3 MJ and 7.5 MJ.  No significant differences between TEU and EER were
found when using a PAL of 1.27. When using a PAL of 1.55 to calculate
EER (respectively 8.6 (0.8) MJ and 8.5 (0.7) MJ) it was higher than TEU in
both groups (p<0.01).
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Dietary intakes were assessed before and during radiotherapy in order to
measure the patients’ compliance to the diet. According to the patients self-
reported dietary intake the intervention group had met the outlines for the
low fat, low lactose diet with respect to fat intake. However, the mean
reported energy intake in both groups was so low that the validity of the
dietary intake data could be questioned. The mean EI: BMRest ratio was
below the cut-off limit of 1.22 in the intervention group during the 48-hour
recall and the food record periods. In the control group it was below the
cut-off during period II of food recording. Values less than the Goldberg
cut-off 2 are generally accepted to indicate underreporting since they reflect
EI incompatible with habitual intake (6,27).  However, the reported dietary
intake can still be a valid estimate of the actual intake during the period of
investigation (27). The low energy intake may have been a result of lack of
appetite and low food intake due to hospitalisation, the impact of
information about the disease and psychological distress. Previous results
from the present study have shown that the women experienced
psychological distress before radiotherapy and reduced appetite and
increased fatigue during radiotherapy (24). In addition it is shown that it
may be difficult to obtain sufficient energy intake on a fat reduced diet
because of increased volume (13).
Validation against urinary nitrogen
During the two periods of food records a good resemblance between
estimates for protein intake and recorded intake was found in both groups,
which should confirm validity (9,10). The recorded protein intake during
period II was more in accordance with the estimated intake than during
period I. This may be explained by the fact that training seems to improve
accuracy of record keeping (8).
Since the urine collections were performed according to Isaksson (10), no
markers were given to verify the completeness. Others have stated that it is
important to validate the urine collections (28).  The fact that we did not
use any markers might imply problems with interpreting our results. If
incomplete collections are used, nitrogen (N) excretion will be under-
estimated and comparison with N intake will give a bias to finding intakes
as valid (28). The patients were however given clear instructions about how
to collect the urine and the collections were mostly conducted at the
hospital under supervision of nurses. Mostly free-living subjects are found
to be unreliable in collecting urine (28,29).  All incomplete samples were
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reported and not included in the analysis. Altogether we are quite sure that
the samples analysed were complete. Our study design was problem
oriented rather than methodical oriented. The main goal was to evaluate the
effect of a diet and we chose to be pragmatic in methodical issues. It was
easier and cheaper to perform the urine collections according to Isaksson
(10) than to use markers to verify the urine collections.
One other problem was the mean weight reduction observed in both groups
during radiotherapy. The use of 24 -hour urine to estimate dietary protein
intake depends on the assumption that subjects are in a steady state or N
balance where intake equals output (9).  Weight reduction lead to a
negative N-balance and the subjects were therefore not in a steady state.
However, some of the individuals experienced a weight reduction and some
experienced a weight gain. This must be reckoned as a normal random
variation and should not necessary produce a bias if the negative N-balance
cancel the positive N-balance. For individuals the discrepancies between
calculated and estimated protein intake may be rather great caused by
changes in the urea concentration in the body fluids due to small day-to-day
variations in urea retention (9,10). This is not considered a problem as long
as the validation is made on a group level.
It may also be questioned if the 24-hour urine N is optimal to validate the
dietary intake among a group of cancer patients since cancer is known to
effect protein metabolism (30). Muscle wasting and failure in adaptation to
decreased food intake with protein depletion has been shown. Such
findings may be of more concern in connection with already malnourished
and cachectic patients. The patients in the present study received curable
treatment and the prognosis was good. Loss of intestinal mucosa due to
radiotherapy may also have resulted in protein depletion. It is however
shown that modern radiotherapy is no more than a modest catabolic
stimulus (31).
The group that collected urine was smaller than the group that recorded
dietary intake. Urine collection is demanding, and some of the patients felt
that it was uncomfortable to do it and were allowed not to. One could argue
that the group who had collected urine was more accurate and
conscientious than those who did not, and that this may have influenced the
result. Participating in a survey may always cause some individuals to eat
or report less and others to eat or report more (6). The validation was made
on a group level and this was therefore not considered as a major problem.
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Weight development
The energy intake corresponded to the changes in body weight during the
intervention period, which strengthens the assumption that the food records
were valid. At period I the total energy used (TEU) was higher than
estimated energy requirements (EER) when using a PAL that allow
minimal movement to predict EER. A correspondence between TEU and
EER was found in both groups when using a PAL of 1.55 associated with a
sedentary life-style (23). At period II, however, the best correspondence
between TEU and EER was found when using the lowest PAL.  The
women reported increased fatigue and malaise during the last week of
radiotherapy (24). This indicates that they were less active during period II
than during period I and therefore different PALs should be used to
calculate EER at the two time points. Because estimates of energy
expenditure are dependent on activity level, one should always include a
questionnaire to obtain information about the subjects' activity.
The major limitation in food records is the tendency for people to eat
differently when recording, and the act of record keeping may itself alter
the respondents' dietary behaviour (7). This limitation is of particular
concern in a diet intervention study because of the potential bias towards
adherence in the low fat intervention. The participants comply when they
are recording, overestimating their reduction in the fat intake to please the
investigator. This assumption is however not likely in this study. The
weight loss found indicates that the patients had a dietary intake between
the two periods of food recording, which did not differ much from the
recorded. During hospitalisation the patients received a diet controlled by
the hospital kitchen. Many reported decreased appetite and it is therefore
unlikely that they would have eaten a lot in addition to the food from the
kitchen. Particular concern should off course be paid to the outpatients. It is,
however, shown that non-compliance to the diet among outpatients may be
of a minor problem (5). It is also found that personal commitment to the
staff seems to motivate subjects to adhere to the diet regimen (5). In the
present study there was often and good contact between staff and the
patients.
In conclusion, both methods used seemed to give a valid estimate of the
dietary intake in the intervention period on which it was possible to make
conclusions about compliance. Even though the EI: BMRest ratios were
below 1.22, a bias towards underreporting of EI it was not indicated. The
reported protein intake corresponded well to the protein intake estimated
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from 24-hour urinary nitrogen excretion. There was also consistency
between energy intake, loss of body weight and estimated energy
requirement.
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Table 1 Patient characteristics.
Intervention Controls
n 71      72
mean (range) mean (range)
Age (yr) 57.1 (29-74) 55.5 (34-74)
Weight (kg) 70.6 (47-119) 67.0 (46-112)
Height (cm) 164.7 (153-180) 163.5 (149-177)
 %  %
Performance 0 89 88
status (WHO) 1 9 10
2 2 1
Diagnosis Cervical cancer stage IA 4 0
Cervical cancer stage IB 22 24
Cervical cancer stage IIA 4 6
Cervical cancer stage IIB 31 39
Endometrial cancer stage I 25 22 
Endometrial cancer stage II 13 8
Ovarian cancer stage IC 0 1
Treatment Surgery 55 47
Radium application 31 35
Brachytherapy 13 19
Other Hypertension 13 14
diagnosis Diabetes Mellitus 4 4
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Table 3  Evaluation of the validity of the 4-day estimated food records
by estimated protein intake.  Period I was three weeks after start of
radiotherapy and Period II the last week of radiotherapy. Significant
differences between the two groups are indicated with * (p<0.05) or **
(p<0.01); t-test. Significant differences within the two groups are indicated
with  p values; pairwise t-test.
Period I Period II    
Intervention Control Intervention Control
mean (SD) mean (SD) mean (SD) mean (SD)
Protein intake (g)
- Calculated   n=62 n=68 n=62 n=67
66.4  (16.2) 60.7 (16.9) 61.7  (16.4) 56.9  (15.5)
- Estimated1 n=49 n=49 n=48 n=52
63.9  (15.4) 59.7 (14.5) 61.3  (17.4) 57.9  (17.5)
P ns ns ns ns
1Protein intake estimated from the equation: 6,25 x (urine nitrogen (g) +2)  
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Table 4  Evaluation of the validity of the 4-day estimated food records
by changes in body weight and ratio between reported energy intake (EI)
and etsimates of basal metabolic rate (BMRest). Study specific cut-off limit
was 1.22.  Period I was three weeks after start of radiotherapy and Period II
the last week of radiotherapy. Significant differences between the two groups
are indicated with * (p<0.05) or ** (p<0.01); t-test. Significant differences
within the two groups are indicated with  p values; pairwise t-test.
Period I Period II    
Intervention Control Intervention Control
mean (SD) mean (SD) mean (SD) mean (SD)
n=62 n=68 n=62 n=67
Energy intake and weight change
- Reported EI (MJ) 6.0   (1.5) 7.0   (1.6) ** 5.7    (1.3) 6.5    (1.6) **
- Weight loss1  (kg) 0.5   (0.6) 0.3   (0.6) 0.4    (0.6) 0.2    (0.6)
- EW2 (MJ) 2.1   (2.7) 1.4   (2.7) 1.6    (2.6) 1.0    (2.4)
- BMRest3  (MJ) 5.6   (0.5) 5.5   (0.4) 5.6    (0.5) 5.5    (0.5)
Energy used
- TEU4   (MJ)  8.1   (3.0) 8.4   (2.7) 7.3    (2.6) 7.5    (2.4)
- EER5   (MJ) 7.1   (0.7) 6.9   (0.5) 7.1    (0.7) 7.0    (0.6)
P <0.05 <0.01 ns ns
Physical activity level
- EI:BMRest ratio 1.07 (0.27) 1.29 (0.30) ** 1.03  (0.25) 1.19  (0.27) **
1Mean weight change per week 2EW=energy contribution from weight change (kg X
(2.1MJ/0.5kg)) 
3 BMRest =basal metabolic rate estimated from the equation: BMR (female)=(655 + 9.6W +
1.7H) - 4.68A,
4TEU=total energy used= EI +EW 5EER=estimated energy expenditure=BMRest X 1.27
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